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Abstract 
Christopher D. Thomas 
Department of Chemistry, November 2010 
The University of Kansas 
 The focus of this dissertation is the desymmetrization of C2-symmetric 1,3-
anti-diols through the construction of pseudo-C2-symmetric phosphorus heterocycles, 
bearing a chirotopic, non-stereogenic center at phosphorus. Diastereotopic 
differentiation is achieved through cyclization via ring-closing metathesis (RCM), 
affording a chiral, non-racemic bicyclic P-heterocycle, which is stereogenic at 
phosphorus.  This strategy is central to building skeletally diverse polyol subunits, 
which are commonly seen in polyketide-based natural products.  Terminus 
differentiation and chain elongation through selective transformations on the 
previously reported bicyclo[4.3.1]phosphate (both antipodes), e.g. cross-metathesis, 
regioselective olefin reduction and regio- and diastereoselective allylic phosphate 
displacements, provide a rapid protocol to accessing the aforementioned motifs.  The 
development of this methodology advanced into an application toward the total 
synthesis of dolabelide C (bearing two separate 1,3-anti-diol containing fragments), 
which exhibits cytotoxicity against cervical cancer HeLa-S3 cells with an IC50 value 
of 1.9 µg/mL.  A route to this target was devised, where the final step was amending 
the 24-membered marcocycle through RCM.  The result provided a diastereomeric 
mixture of E and Z isomers, which proved to be difficult to separate during initial 
efforts.  However, LC-MS analysis of the mixture showed the contaminants were by-
 iv 
products arising from isomerization events occurring prior to RCM.  Other reports 
coincide with this observation, mainly in the synthesis of medium to larger sized 
rings. Scale-up was required after this initial study to provide ample material for final 
characterization and the re-synthesis provided a copious amount of the RCM 
precursor.  The large amount of material allowed for optimization studies and finally 
resulted in 14 mgs of analytically pure dolabelide C and 10 mgs of the non-natural Z-
isomer, which to the best of our knowledge is the first synthesis of both compounds 
and the most synthetic material available of each to date. 
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Chapter 1 
Phosphorus and Sulfur Heterocycles via Ring-Closing 
Metathesis: Applications in Total Synthesis 
 
 
 
 
 
 
 
2 
1.1 Introduction 
The development of new synthetic strategies allowing for the efficient 
asymmetric syntheses of complex biologically active targets, with minimal protecting 
group manipulations and chemical steps, is an enormous challenge in natural product 
synthesis.  An effective way of addressing this challenge is through the use of 
convergent methodologies employing the temporary tethering of two advanced 
intermediates.  Historically, silicon has been the most widely used temporary tether 
due to its facile installation/cleavage attributes as well as its innate protecting group 
properties.
1
 Moreover, the ability of silicon tethers to undergo myriad of functional 
group transformations positions them as ideal tethers in the realm of total synthesis.
2
 
Phosphorus and sulfur, namely phosphates and sultones, possess alternative 
properties as tethers in that they can serve as leaving groups mediating a variety of 
nucleophilic substitution reactions while retaining orthogonal stability.  Both tethers 
can also serve as the central linchpin in the formation of the corresponding 
heterocycle via ring-closing metathesis (RCM) catalyzed by the well-defined olefin-
metathesis First (cat-A) and Second (cat-B) Generation Grubbs
3
 and Hoveyda-
Grubbs
4
 (cat-C) catalysts (Figure 1), which have also served an important role as an 
effective transformation in the total synthesis of natural products.
5  
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Figure 1 
In addition, their facile cleavage resulted in by-products that are easily 
removed through aqueous workup (phosphine oxide)
6 
or extrusion (SO2).
7,8
 Rapid 
access to complex, functionalized intermediates have allowed these methodologies to 
emerge in the realm of natural product synthesis.
8,9 
1.2 Sulfur Heterocycles 
1.2.1 Synthesis and Reactivity of Sultones Derived from RCM 
 In 2002, Metz et al. reported the first synthesis of an unsaturated sultone 1.4 
resulting in a method producing a variety of ring sizes.
10
 These heterocycles were 
achieved in a two-step protocol starting from a variety of olefinic sulfonyl chlorides 
1.1 and alkenols 1.2 (Scheme 1).  
4 
Scheme 1 
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 In 2003, Cossy and coworkers demonstrated the ability to construct sultones 
from secondary alkenols, thus augmenting previous work by Metz with primary 
alkenols.
7
 The unsaturated sulfonates derived from secondary alkenols (1.5, Scheme 
2) were more difficult to construct and exhibited reduced stability.  This problem was 
circumvented by subjecting the crude sulfonates 1.6 to catalyst cat-B (C6H6, 70 ºC) 
thus affording a variety of substituted unsaturated sultones 1.7 in good yields 
(Scheme 2). 
Scheme 2 
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 The aforementioned heterocyclic building blocks possess the potential for 
exploring numerous reaction pathways.
11
 Hence, Cossy and coworkers highlighted !-
alkylation of various sultones 1.8 in the presence of n-butyllithium followed by the 
addition of different alkyl halides (Scheme 3).
8
 The choice of base was also found to 
be crucial, as the use of LDA resulted in formation of a sulfene intermediate, which 
rapidly dimerized to product 1.10 through a [2+2]-cycloaddition. 
Scheme 3 
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 The leaving group ability of the sultone was exploited in an innovative 
alkylation/elimination sequence.  The removal of the tether is facilitated by 
metallation of 1.11 (n-BuLi) and treatment with iodomethylmagnesium chloride 
(from CH2I2, i-PrMgCl, THF, -78 ºC)
 
to produce the reactive Grignard species 1.12.  
This species undergoes subsequent "-elimination resulting in loss of SO2 to afford 
6 
homoallylic alcohols bearing 1,3-dienes with an internal Z-disubstituted olefin and a 
terminal or !,!-disubstituted alkene, 1.13a/1.13b, respectively (Scheme 4).8 
Scheme 4 
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 A number of bioactive natural products possess a similar homoallylic 
conjugated Z-dienol which can be produced from a sultone heterocycle (Figure 2).
12
 
The approach of Cossy et al. to this synthon is unique compared to previous 
methodologies that do not utilize olefin metathesis to afford the internal Z-olefin of 
the 1,3-dienol.
13
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Figure 2 
1.2.2 Total Synthesis of (±)-Mycothiazole (The Originally Proposed Structure)  
 The development of a method towards constructing conjugated Z-dienols led 
Cossy and coworkers to pursue the total synthesis of (±)-mycothiazole,
8
 with the 
originally proposed structure
14
 outlined in Scheme 5.  The synthesis was designed for 
the C7-C11/C20 subunit to be accessed through formation of a sultone tether from 
homoallylic alcohol 1.15 through sulfonylation and RCM (Scheme 5).  Subsequent 
alkylation of the !-position to the sulfonyl would afford requisite functionalization to 
append the C12-C13 side chain.  Overall, the retrosynthetic approach started from 
8 
readily available 2,4-dibromothiazole (1.17),
8
 which established the necessary 
connectivity for the uniquely substituted thiazole ring. 
Scheme 5 
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 The key sequence began with the formation of the sultone derived from the 
advanced homoallylic alcohol 1.15, where sulfonation and subsequent RCM with cat-
B afforded sultone 1.18, bearing the necessary C9-C10 Z-olefin, as a single 
diastereomer in 70% yield over two steps (Scheme 6).  Subsequent alkylation of the 
sultone with 1,1-dimethoxy-3-iodopropane, furnished sultone 1.19 as a 1:1 mixture of 
diastereomers at C11.  Construction of the dienol commenced via deprotonation of 
1.19 with n-BuLi followed by addition of ICH2MgCl (supplying the C20 terminal 
methylene group), yielding the desired Z-dienol 1.20 in 60% yield.
8
  
9 
Scheme 6 
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 Following assembly of the key C9-C11/C20 subunit, conjugated Z-dienol, 
dimethyl acetal 1.20 was converted to the required carbamate in 33% yield over four 
steps, achieving a racemic synthesis of the originally proposed structure of 
mycothiazole in 5% overall yield and 18 steps from 2,4-dibromothiazole 1.17 
(Scheme 7).
8
  This was the first example of utilization of a sulfur-mediated tether in 
the context of the total synthesis of a biologically active natural product.
  
Overall, the construction of sultones via sulfonation/RCM from the 
corresponding allylic alcohol fulfills the requirements of an effective temporary tether 
in synthesis.  The sultone functionality provides sufficient reactivity under basic 
conditions to afford complex Z-substituted 1,3-dienols after the facile removal of the 
sulfonyl through the extrusion of SO2.  The prospect of utilizing additional selective 
10 
reaction pathways has the potential to generate new synthons furnishing a variety of 
pathways to biologically active natural products.
7,8
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1.3 Phosphorus Heterocycles 
1.3.1 Synthesis and Reactivity of Phosphates from RCM 
 Despite enormous research on organophosphorus compounds, the general use 
of phosphate triesters in synthesis has been relatively limited until recently.  
Phosphorus has inherent properties that make it an attractive tether candidate, 
including the ability to mediate di- and tripodal coupling, provide orthogonal 
11 
protection and serve as a leaving group.  Irrespective of these attributes, the 
application of phosphates in synthesis is largely centered on monovalent activation of 
a single phosphate ester appendage.  Such classical use of phosphates in complex 
synthesis focus on nucleophilic displacement reactions of allylic phosphates,
15 
cross-
coupling/reduction reactions with enol-phosphates,
16
 and more recent applications 
employing direct displacements of phosphates in cyclization protocols.
17
 Additional 
uses of phosphate triesters in iodophosphonylation procedures
18
 and their role in 
oligonucleotide synthesis
19
 further highlight both nucleophilic properties and facile 
coupling characteristics innate to phosphates.  These reaction processes utilize the 
leaving group ability of a phosphate monoanion, where a single ester moiety is 
activated (monovalent activation) and the remaining ester positions serve as ancillary 
substituents.  
 In 2005, Hanson and coworkers investigated the possibility of exploiting both 
multipodal coupling and multivalent activation attributes within phosphate triesters, 
which by their nature presented opportunities to investigate selective processes.  This 
study resulted in a new method that embodied several underdeveloped areas of 
phosphate chemistry, namely their use as removable, functionally active tethers 
capable of multipodal coupling and multivalent activation and their subsequent role 
as latent leaving groups in a number of unprecedented selective cleavage reactions.  
In addition, stereoelectronic effects within the bicyclic framework lend orthogonal 
protecting group stability.  In 2005, Hanson and coworkers implemented this protocol 
for constructing cyclic phosphates from allylic alcohols
6c
 and 1,5-diene-2,4-diols
6a
 to 
12 
yield unique mono- and bicyclic heterocycles that undergo several selective 
transformations while imparting orthogonal stability.  The utilization of a tether to 
desymmetrize a C2-symmetric diol was inspired by the work of Burke et al., who 
demonstrated that ketalization of 1,5-diene-3,4-diol 1.21 with 5-chloropentan-2-one 
and subsequent elimination of the primary chloride with tert-butoxide could generate 
triene 1.22 (Scheme 8).
20
 After undergoing cyclization in presence of cat-A, RCM 
afforded chiral, non-racemic bicycle 1.23 in 86% yield.  Diastereotopic differentiation 
of the pseudo-C2-symmetric ketal 1.22 using RCM was facilitated by the proximity of 
the newly installed allyl group, which allowed the differentiation of the previously 
homotopic terminal vinyl groups.  
Scheme 8 
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 In 2005, Hanson and coworkers utilized this concept with a phosphate tether 
in the desymmetrization of C2-symmetric (3S,5S)-1,6-diene-diol (S,S)-1.24 (Scheme 
9).
6a
 After coupling with POCl3, allyl alcohol was added to the phosphoryl chloride 
13 
species, yielding phosphate triene (S,S)-1.25.  In the presence of cat-B (Figure 1), the 
proximity of the two 1,3-diaxial terminal olefins in ring conformer 1.25a allowed for 
facile RCM affording the P-chiral, nonracemic bicyclo[4.3.1]phosphate scaffold  
(S,S,SP)-1.26. 
Scheme 9 
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 The nature of bicyclo[4.3.1]phosphate (S,S,SP)-1.26, showed promise in 
pursuing selective transformations, whereby the tripodal phosphate tether imparts 
multivalent activation of the three carbinols en route to differentiated polyol 
fragments.
6a
 Consistent with previous reports of cyclic phosphines and phosphates, it 
was shown that in acidic media, 1.26 exhibited excellent stability due to the decrease 
in proton affinity (basicity) of the phosphonyl oxygen (eq. 1, Scheme 10), thus 
hindering activation pathways.
21
 Different nucleophiles were shown to yield selective 
reaction pathways through their hard/soft characteristics.
22
 First, addition of LiAlH4 
resulted in hydride addition to phosphorus resulting in facile removal of the 
14 
phosphate thus affording triol 1.27 (eq. 2, Scheme 10).  This result supports the 
ability of the phosphate to be utilized as a temporary tether in coupling diol 1.24 with 
allyl alcohol through a phosphate-mediated sequence.
6a
 Basic hydrolysis (eq. 3, 
Scheme 10) also resulted in attack at phosphorus, however due to the characteristics 
of the phosphate mono-anion,
23
 an excess of LiOH only displaced one of the three P-
O bonds, yielding phosphate acid 1.28.  Variation from an oxygen nucleophile to a 
softer sulfur nucleophile such as LiSPh (eq. 4, Scheme 10) demonstrated the 
preference for addition onto the most sterically accessible C3 carbinol position, 
furnishing phosphate acid 1.29.  Lastly, cuprate addition resulted in allylic 
displacement of the more sterically accessible olefin (eq. 5, Scheme 10), resulting in 
phosphate acid 1.30, along with preferential formation of the E-isomer, which is 
consistent with previous reports in the field of cuprate additions to allylic 
phosphates.
24
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 The preference of cuprate nucleophiles to add into the more sterically 
accessible olefin of 1.26 led into examining the possible functionalization of the 
endocyclic olefin.
6a
 After regioselective hydrogenation of the exocyclic olefin in the 
presence of Wilkinson’s catalyst, cuprate addition to phosphate 1.31 preferentially 
occurred at the C5 position with high regioselectivity (Scheme 11).  Removal of the 
phosphate acid with Red-Al produced diol 1.32 bearing an 1,3,4-anti,anti-stereotriad, 
as a single diastereomer over the three-step sequence from (S,S,SP)-1.26. 
Scheme 11 
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 The remarkable regioselectivity in this transformation is attributed to inherent 
stereoelectronic effects of the C4-C5 olefin and P-O bond of the corresponding allylic 
phosphate.  For addition into the C5 position (path A, Figure 3, X-ray of structure 
1.26), orthogonal alignment of the #* orbital of the C=C bond and $* orbital of the P-
O provide proper electronics for the allylic displacement to occur.  However, in a 
potential C4 addition (path B, Figure 3), SN2’ addition does not take place due to 
coplanar alignment of the aforementioned #* orbital of the C=C bond to the P-O $* 
orbital.
6a
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Figure 3 
 Facial selectivity was attributed to the overall geometry of the bicyclic 
skeleton of 1.26, whereby the bicyclo[4.3.1]phosphate system, hinders approach of 
the cuprate from the concave face (Figure 4, X-ray of structure 1.26).
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Figure 4 
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Another highlight of selective functionalization of (S,S,SP)-1.26 was seen in 
hydroboration (Scheme 12).
6a
 Addition of 9-BBN across the exocyclic olefin, 
followed by mild oxidation of the corresponding borane (NaBO3•4H2O)
25
 furnished a 
primary alcohol,
26
 which was protected with TBDPSOTf to give silyl ether 1.33 in 
good yield.  Further conversion to triol 1.34
27
 was accomplished first by cuprate 
addition and methylation of the resulting phosphate acid to a more convenient 
phosphate ester for handling and reductive removal (Red-Al) (Scheme 12).
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The utility of the phosphate tether for the rapid generation of advanced polyol 
subunits is highlighted in Scheme 13.  After coupling diol (S,S)-1.24 with chiral 
allylic alcohol 1.35, successful RCM gave the complex phosphate 1.36.  Hydrolysis 
of the phosphate yielded 1.38 as the phosphate lithio-salt in 3 steps from 1.24.  
Exhaustive hydrogenation
28 
of both olefins (H2, 500 psi) and quantitative phosphate 
cleavage (LiAlH4) afforded the polyol subunit 1.39 in an efficient 4-step protocol 
from 1.24.
6a  
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Overall, a number of selective nucleophilic additions to (S,S,SP)-1.26 have 
been demonstrated.  These observations highlight the ability of multivalent activation 
in phosphate triesters to rapidly access complex, differentiated polyol subunits, which 
are applicable to natural product synthesis. 
1.3.2 Reactivity of Phosphate 1.26 in Cross-Metathesis 
Cross-metathesis (CM) studies were explored with (R,R,RP)-1.26, with the 
aim of observing a regioselective of the exocyclic olefin and also determining the 
reactivity of 1.26,
29
 allowing insight to its compatibility with a variety of cross-
partners.  First, the reactivity was probed in subjecting (R,R,RP)-1.26 with methyl-
vinyl ketone (MVK) with three different methathesis catalysts (Table 1).
6b 
Results 
showed excellent regioselectivity, yielding 1.40, in all of the conditions screened 
19 
along with the optimal parameters utilizing cat-C and a slight increase of MVK (entry 
5) in comparison to entries 1-4. 
Table 1 
 
(R,R,RP)-1.26
entry catalyst % yield
O
conc./ solvent
1
2
0.05 M/ CH2Cl2
0.05 M/ CH2Cl2
0.05 M/ CH2Cl2
<5a
25a
75b
0.1 M/ CH2Cl2 71
b,c
4
5
O
P
O O
O
O
P
O O
O
cat-A
cat-B
cat-C
0.1 M/ CH2Cl2 26
a3
1.40
O
cat-B
cat-C
a Conversion determined by 31P NMR. 
b Yields determined by isolated, purified products. 
c Used 4.0 equiv of MVK.
(3 eq.)
10 mol %
catalyst
 
 With the ideal conditions in hand, a variety of cross-partners were screened.  
Observations revealed that 1.26 was reactive with type I (rapid homodimerization) 
and type II (slow homodimerization)
29
 olefins, providing good yields and good to 
excellent E:Z ratios (Table 2). When attempting to undergo CM with type III partners, 
very poor yields were observed.  In accordance with Grubbs classification of CM 
partners, type III olefins do not undergo homodimerization, and are therefore ideal 
hetero-partners with substrates bearing type I and II olefins and unreactive with 
substrates possessing type III olefins.
29
 Based on these results and the fact that 1.26 
did not undergo homodimerization, the exocyclic olefin in 1.26 (also assumed for the 
(S,S,SP)-antipode) was deemed to be type III.
6b
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Table 2  
O
H
O
MeO
72
78
78
8:1
>99:1
>99:1
HO
BnO
O
t-BuO
60 5:1
HO >99:1
69
% yield
CM
partner
E/Z
TBSO
BocNH
86
87 >99:1
>99:1
(MeO)2PO
80 2:1
Type
I
I
I
I
II
II
II
II
<5
NC
<5
N.R.
N.R.
O
MeO
n/a
n/a
n/a
n/a
III
III
III
O
% yield
CM
partner
E/Z Type
none
(R,R,RP)-1.26
O
P
O O
O
O
P
O O
O
R
CH2Cl2, 50 ºC
3-6 h
1.41
CM partner
cat-C 
(10-12 mol %)
 
The key result from this study is the ability to use metathesis as a rapid means 
to desymmetrizing C2-symmetric diol (R,R)-1.24 (Scheme 14).  It can be seen that 
each of the homotopic termini of 1.24 is selectively differentiated through the 
construction of tetrol 1.43 after reductive removal (LiAlH4) of the phosphate tether.
6b
 
A wide array of cross-partners can also be utilized via this approach, since the type III 
reactivity of the exocyclic olefin of 1.26 allows for high selectivity with type I and II 
olefins, especially cross-partners bearing higher levels of complexity (vide infra). 
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By combining the cross-metathesis and cuprate methodologies, an advanced 
intermediate 1.48 containing key aspects of the dolabelide family was constructed 
(Scheme 15).
30a
 Hence, phosphate-mediated coupling of (R,R)-1.24 with 1,1-
dimethylallyl alcohol afforded the bicyclic phosphate 1.44 over a three-step sequence.  
Cross-metathesis of the latter with but-3-en-1-ol in the presence of cat-C and 
subsequent hydrogenation of the exocyclic olefin of 1.45 furnished an extended side-
chain (1.46) bearing the C15-C19 structure of dolabelide.  After benzylation of the 
primary alcohol in 1.46 with p-methoxybenzyl trichloroacetimidate, addition of a 
methyl cuprate, methylation of the phosphate acid (TMSCHN2) and removal of the 
phosphate ester (Red-Al) yielded advanced intermediate 1.48, a key synthon toward 
the synthesis of dolabelide C.
6b  
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 The differentiated 1,3,4-anti,anti-stereotriad seen in 1.48 is also present in a 
number of biologically active natural products, including dolabelides C, bitungolide 
E, (+)-discodermolide, dictyostatin and salicylihalamide A (Figure 5).
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Figure 5 
1.3.3 Efforts Toward the Synthesis of Dolabelide C 
Dolabelides A-D were isolated from a sea hare, dolabella auricularia.
30a
 To 
date, Leighton’s total synthesis of Dolabelide D stands as the lone synthesis of any 
member in this family.
31
 In 2008, Hanson and coworkers reported the synthesis of 
two key subunits of dolabelide C, possessing the 1,3-anti-diol motif observed at the 
C7/C9 positions and the 1,3,4-anti,anti-diol subunit at the C19/C21-C22 positions.  
Retrosynthetic analysis segmented the 24-membered macrolide into a C1-C14 subunit 
1.49 and C15-C30 subunit 1.50 from disconnecting the lactone bond and C14-C15 
olefin (Scheme 16).
9
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 Each subunit was constructed by a phosphate-mediated desymmetrization of 
1.24, followed by the aforementioned CM and allylic phosphate displacements.  The 
C1-C14 subunit was envisioned to have the C1-C6 side chain appended via CM to 
yield advanced intermediate 1.51 from (R,R,RP)-1.26.  Subsequent regioselective 
hydrogenation of the C5-C6 olefin and regioselective Pd(0)-mediated allylic hydride 
addition (to C11) would afford a terminal olefin armed for oxidation and subsequent 
installation of the C11 carbinol center (Scheme 17).
9a
 The C15-C30 subunit largely 
depended on the CM/cuprate approach and the advanced intermediate 1.52 would be 
synthesized from (S,S,SP)-1.26.
9b 
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 The synthesis of the C1-C14 subunit was initiated from readily available 
(R,R,RP)-1.26, which was coupled with olefin 1.53, possessing the necessary C2-C4 
stereochemistry, by CM in the presence of cat-C (Scheme 18).  Regioselective 
hydrogenation of the external olefin in 1.54 was accomplished using in situ formation 
of diimide from o-nitrobenzenesulfonyl hydrazine (o-NBSH)
32
 and Et3N to provide 
partially reduced phosphate 1.55.  This was followed by another regioselective ring-
opening, and a Pd(0)-mediated reduction of allylic phosphate 1.55 via formation of 
hydride from formic acid and Et3N.
33
 Overall, this transformation resulted in an 
allylic displacement of the endocyclic phosphate with hydride, which after 
methylation with TMSCHN2 yielded phosphate ester 1.56.  Removal of the phosphate 
ester with LiAlH4 produced advanced intermediate 1.57, bearing the C1-C10 
framework.
9a  
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 Introducing Pd(0) to phosphate 1.55 gave rise to #-allyl complex 1.55a 
(Scheme 17).  The Pd(0)-mediated allylic hydride addition
9a
 to phosphate 1.55 gave 
the desired regioselectivity of hydride addition at the internal position (C10) of 1.55a 
(regioselectivity C10/C12 = 37:1), similar to the previous cuprate additions to 1.26.  
Both examples are illustrative of the preference in regioselectivity of allylic 
phosphate displacements with the endocyclic #-bond. 
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 The C15-C30 subunit was synthesized by means of two approaches. Initially, 
regioselective hydroboration
25
 of the exocyclic olefin in (S,S,SP)-1.26, followed by 
PMB-protection of the primary alcohol provided 1.58 (Scheme 20).
9b
 Allylic 
displacement using a methyl cuprate derived from Me2Zn and CuCN•2LiCl furnished 
the aforementioned 1,3,4-anti,anti-stereotriad of the C19/C21-C22 subunit as a single 
diastereomer.  Methylation of the phosphate acid and cleavage of the resulting 
phosphate ester 1.59 with LiAlH4 afforded 1,3-diol 1.60 over the five-step sequence 
from bicyclic phosphate 1.26.
9b
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 An alternative route utilized cross-metathesis of (S,S,SP)-1.26 and PMB-
protected pent-4-en-1-ol to give phosphate 1.61 (Scheme 21).  Selective 
hydrogenation of the exocyclic olefin gave 1.62, which possesses the C15-C18 side 
chain of the C15-C30 subunit.  Again, allylic displacement with a methyl cuprate 
derived from Me2Zn and CuCN•2LiCl occurred regioselectively and gave phosphate 
1.63 (after methylation with TMSCHN2).  Phosphate cleavage with LiAlH4 afforded 
1,3-diol 1.64 in a five-step protocol from 1.26 in higher overall yields than the 
previous route, providing the C15-C18 framework intact.
9b 
Scheme 21 
Me
OPMB
1.61
P = PMB
(S,S,SP)-1.26 1.62
P = PMB
cat-C (6 mol %) 
DCE, 90 ºC
3
 Et3N, CH2Cl2
75%
1. CuCN•2LiCl, Me2Zn
O O
SO2NHNH2
NO2
2. TMSCHN2, MeOH, 
91%
18
15 OPMB
82%
P
O OMe
LiAlH4, 92%
Me
OH OH
18
15 OPMB
dr > 99:1 1.63 1.64
O O
O
P
O
O O
O
P
O
PO
3
O O
O
P
O
PO
18
 
29 
Final steps to completing the C1-C14 framework included acetonide 
protection, followed by ozonolysis of the terminal C11-C12 olefin and Grignard 
addition (derived from 1-iodo-3-methyl-3-butene) to produce 1.65 (Scheme 22).  
Oxidation of the C11 carbinol (Dess-Martin periodinane) and removal of the 
acetonide using CeCl3•7H2O set the stage for a stereoselective reduction of 1.66 using 
Evan’s syn-reduction
34
 conditions (20:1 ds of desired C11 epimer), affording all of 
the necessary stereocenters (1.67) in 13 steps from phosphate (S,S,SP)-1.26.
9a 
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 Efforts toward completing the carbon framework of the C15-C30 subunit were 
investigated using both 1,3,4-anti, anti diols, 1.60 and 1.64, which were both 
orthogonally protected and their olefins (1.68 and 1.70) oxidized to their respective 
aldehydes, 1.69 and 1.71 (Scheme 23).
9b 
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Final steps toward the C15-C30 fragment were completed via two different 
stereoselective generation of the C23 carbinol and the construction of the terminal 
C15 olefin. Diastereoselective vinylate addition (generated from 1.72) yielded the 
desired epimer of 1.73 in 11:1 dr from the reagent-controlled step.
35
 After protecting 
the newly formed C23 carbinol (MOMCl), the primary carbinol of 1.75 was 
debenzylated (DDQ), tosylated and substituted with a allyl-based cuprate yielding the 
C15-C30 subunit (1.76) of dolabelide C. 
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 A conformationally controlled oxidation/reduction protocol also achieved 
good levels of stereoselectivity, where vinylate addition (generated from 1.72) into 
1.71 gave a 1:1 mixture of epimers at C23 (Scheme 25).
9b
  The undesired epimer was 
separable and recycled through oxidation (Dess-Martin periodinane) and a 1,3-syn-
hydride reduction with LiI
36
 provided a 5:1 dr favoring the desired C23 epimer.  After 
protecting the newly formed C23 carbinol (MOMCl), the primary carbinol of 1.78 
was debenylzated (DDQ), iodinated and eliminated with t-BuOK to yield the C15-
C30 subunit (1.76), where both routes provided a 13-step synthesis from phosphate 
1.26.
9b 
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1.3.4 Formal Synthesis of (–)-Salicyhalimide A 
 (–)-Salicylihalamide A, a potent inhibitor of melanoma cell lines and 
mammalian V-ATPase,
37
 was targeted by the Hanson group utilizing their phosphate-
mediated approach to constructing a similar 1,3,4-anti,anti-stereotriad observed in 
32 
dolabelide C.
38
  The synthetic strategy gave rise to two potential common 
intermediates (1.79 and 1.80) previously reported in the literature.
39,40
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 From phosphate 1.81 (3 steps from (R,R,RP)-1.26) 1,3-anti-diol 1.84 was 
synthesized first from cross-metathesis with cat-C and cis-1,4-butene-diacetate, 
providing 1.82.  Pd(0)-formate reduction
33
 and reductive phosphate removal yielded 
1.86, which was a pivotal intermediate for accessing 1.79 and 1.80 (Scheme 27). 
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 Advancing diol 1.84 through orthogonal protection and subsequent 
deprotection furnished intermediate 1.85 over 3 steps (Scheme 28).  Esterification 
under basic conditions with dioxinone 1.86 gave ester 1.87 in 66% yield.  
Methylation of the resultant phenol gave ether 1.88, which was refluxed with cat-A to 
initiate an RCM yielding known macrocycle 1.79
39
 and giving a 12-step protocol 
from (R,R,RP)-1.26. 
Scheme 28 
OH
Me
OH
O
OOMe
OMOM
Me
OPMB
O
OOH
OMOM
Me
OPMB
OMOM
Me
OH
NaH, MeI
THF
0 ºC to rt 
1 h, 90%
O
OOMe
OMOM
Me
OPMBcat-A, 
10 mol%
CH2Cl2, 40 ºC
PMBO PMBO
1) TIPSOTf, 86%
2) MOMCl, 92%
3) TBAF, 95%
OO
O
1.86
MeMe
NaH, 0 ºC to rt
6 h, 66%
 82%
E/Z = 10:1
1.84 1.85
1.871.881.79  
 Alternatively, this synthesis was streamlined by performing the esterification 
on diol 1.84 (Scheme 29).  Treating 1.84 with NaHMDS and addition into dioxinone 
1.86 gave ester 1.89 in 65% combined yield with its regioisomer in a 3.6:1 ratio 
(undesired regioisomer could be recycled through transesterification).  Bis-
etherificaton of the resulting diol with MOMCl and RCM reduced the number of 
steps significantly (12-step to 8-step protocol) yielding known intermediate 1.80.
40
 
Utilizing a similar fragment from the protocol to construct polyols bearing the 1,3,4-
34 
anti,anti-stereotriad, a concise formal synthesis of salicylihalamide A was realized 
using a phosphate-mediated process. 
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1.3.5 Total Synthesis of (–)-Tetrahydrolipstatin 
 The natural product-based antiobesity drug, (–)-tetrahydrolipstatin,
41
 was 
synthesized via the Hanson group's phosphate-mediated methodology.
42
 While there 
were several total syntheses existing in the literature,
43
 this approach is the most 
streamlined to date of this target.   Efficiency was gained through a tandem 
RCM/CM/H2 from 1.25 to 1.91, reducing the amount of linear steps significantly 
(Scheme 30).  The generation of 1.91 was achieved using this one-pot procedure first 
from 1.25, which was synthesized from (S,S)-1.24 via an alterative method through a 
two-step, one-pot phosphorylation with allyl tetraisopropylphosphoramidite and 
subsequent oxidation with m-CPBA.
42 
Under refluxing conditions in CH2Cl2, first 
35 
RCM was accomplished with 3 mol % of cat-B followed by the addition of 1-
undecene and 10 mol % of cat-C.  The reaction was then cooled to room temperature 
and sequential addition of Et3N and o-NBSH
 
furnished phosphate 1.91 in 40% overall 
yield (~74% yield per step) over the multi-step procedure. 
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 With phosphate 1.91 in hand, cuprate addition, derived from n-hexyllithium, 
provided the 1,3,4-anti,anti-stereotriad (1.92) seen previously (Scheme 32). 
Phosphate 1.92 was carried through 6 synthetic steps leading to alcohol 1.93, which 
was primed for Mitsunobu inversion
44
 through a previously reported protocol
43a
 
finished the construction of (–)-tetrahydrolipstatin in an 8-step linear synthesis from 
(S,S)-1.24. 
36 
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1.4 Conclusion 
 The use of temporary tethers in synthesis represents a powerful approach to 
the coupling of two advanced structures en route to more advanced synthons.  Ring-
closing metathesis plays a key role in the construction of sultone and phosphate 
heterocycles providing effective methods where both sulfur and phosphorus serve as 
temporary tethers mediating several selective transformations. The use of sultones to 
construct 1,3-dienols possessing an internal Z-olefin has been utilized in the synthesis 
of the originally proposed structure of (±)-mycothiazole and has the potential of 
expanding to other biologically active natural products.  Phosphate tethers have 
served a central role in the construction of asymmetric 1,3-anti-diol subunits, which 
have been demonstrated in the construction of both the C1-C14 and C15-C30 
subunits of dolabelide C, a formal synthesis of (–)-salicylohalamide A and a total 
37 
synthesis of (–)-tetrahydrolipstatin. 
 
Additional uses of these versatile heterocycles are 
in order and will be reported in future studies.  
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Asymmetric Synthesis of 1,3-anti-Diol-Containing Subunits  
using Phosphorus-Based Tethers 
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 2.1 Introduction 
2.1.1 Terminus Differentiation and Chain Elongation 
 Polyols are essential building blocks in Nature's construction of an array of 
polyketide-derived natural products.
1
 One challenge for the synthetic chemist is 
replicating the exquisite selectivity displayed by the enzymatic processes to piece 
together structures of high skeletal diversity.  The 1,3-anti-diol subunit is prevalent in 
several natural products bearing a wide array of biological activities.
1
 Common 
approaches to these building blocks are through stereoselective aldol reactions, 
reduction of 1,3-hydroxyketones and 1,3-diketones, and addition reactions to 1,3-
hydroxyaldehydes (e.g. alkylation, allylation and crotylation).
1c 
Another common 
approach to rapidly accessing complex 1,3-anti-diol intermediates is through 
desymmetrization through chain elongation of a readily accessible 1,3-anti-diol 
building block.
2
 Schreiber describes four strategies for the synthesis for acyclic 
chains, which can be applied for short chains that are either a racemate or 
enantiomerically pure (Figure 1).
2b
  
The first case entailed in Figure 1 is the differentiation of meso or achiral 
chains (eq 1).
2
 Requirements to achieving terminus differentiation are through the use 
of substrate-controlled reactions.  Using chiral, non-racemic reagents for this goal 
must be added sequentially in order to obtain a chiral, non-racemic product. 
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Figure 1 
 C2-symmetric chains (eq 2) contain homotopically equivalent groups that can 
be differentiated without selective functionalization.  Psuedo-C2-symmetric substrates 
(eq 3) are termed "pseudo," because without the central carbon center the chain would 
be C2-symmetric.  However, the central center is not stereogenic, but is chirotopic, 
non-stereogenic, because both faces are homotopic.  However, because of the 
prochiral nature of the central carbon, the termini are now diastereotopic and can be 
differentiated through a group selective transformation that will also simultaneously 
convert the central carbon into a stereogenic center.  Lastly, non-symmetric chains 
(eq 4) are accessed through double addition of chiral or achiral reagents to racemic or 
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non-racemic chains.  Differentiation is achieved through selectively functionalizing 
between two different chemical environments. 
2.1.2 Desymmetrization Thru Pseudo-C2-Symmetric Intermediates 
 This research is concentrated on the C2-desymmetrization of chiral, non-
racemic diol substrates through synthesizing pseudo-C2-symmetric intermediates. 
One of the earlier examples of this type of terminus differentiation was by Hoye and 
coworkers
3
 where C2-symmetric keto-diacid 2.1 was reduced with Li/NH3 to generate 
pseudo-C2-symmetric lithiate 2.2 (Scheme 1).   Acidification of the 2.2 under pH ~3 
(kinetic control) and pH ~1 (thermodynamic control) led to mixtures of cis- and 
trans-lactones 2.3 and 2.4 respectively. 
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 The selectivity shown in Scheme 1, where the trans-lactone is predominant, is 
attributed to 1,7-
4
 (shown in 2.5) and 1,6-interactions (shown in 2.6) building up in 
the chair-like conformations (R
2
 = CH2C(Me)CO2H) formed in attack of the free 
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hydroxyl on the carboxylic acid (Scheme 2).  As steric bulk increases from R and R
1
 
= H to both R and R
1
 = Me, the trans-conformer becomes predominant (1:350, entry 
1, Scheme 1).  This study developed an effective method to desymmetrizing a 
symmetric chain by use of a functional group that resides on a symmetry element.
3
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 In their synthesis of 17-deoxyroflamycoin, Rychnovsky and coworkers 
employed a Prins cyclization strategy to desymmetrize C2-symmetric diol 2.9 
(Scheme 3).
5
  By generating pseudo-C2-symmetric acetal 2.10, subjection to Lewis 
acidic conditions (BF3•Et2O) and acyl trapping
6
 with acetic anhydride, afforded the 
trans-tetrahydropyran 2.11 in 42-51% yield over 2 steps.  This advanced intermediate 
was crucial in synthesizing the macrocyclic 17-deoxyroflamycoin (derived from 
roflamycoin),
7
 which contains numerous 1,3-diol subunits within its structure. 
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   One of the more recent examples of this approach is by the Metz group, by 
constructing C2-symmetric dione 2.12 from a multistep synthesis starting with 2-
butyne-1,4-diol (Scheme 4).
8
 Dihydroxylation afford pseudo-C2-symmetric diol 2.13 
that was differentiated through intramolecular acetalization furnishing 2.14, which 
was peracetalated with acetic anhydride to yield 2.15 in 59% yield over 2 steps.  The 
conformational preference is based toward ketalization of carbinol a (from structure 
2.13) where carbinol b is locked in an axial conformation and cannot cyclize with the 
other diastereotopic methyl ketone.  The subsequent ketalization is also differentiated 
by the fact carbinol c, in its equatorial position, is also not at a favorable position, 
thus resulting in ketal 2.14 as a single stereoisomer.   
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 An interesting result was obtained from changing the carbinol protecting 
groups from acetonide to benzyl, where using a similar synthetic route from 2-
butyne-1,4-diol to C2-symmetric dione 2.16 and dihydroxylation provided pseudo-C2-
symmetric diol 2.17 (Scheme 5).  Hydrogenation or acidification gave epimer 2.18 as 
the major product after peracetylation of each resulting tetrol.
8 
The key to achieving 
the different carbinol ketalization (carbinol b over a) was the rate of debenzylation 
was crucial in selectivity.  Compound 2.15 was also converted to 2.18 by subjection 
to a high concentration of HCl at low temperature.  This model study provided crucial 
insight to Metz and coworkers efforts toward the zaragozic acids/squalestatins, in 
which the heterocyclic core of these bioactive species was achieved through this 
method.
9
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2.1.3 Diastereotopic Differentiation Strategy Through P-Heterocycles 
 The strategy developed was desymmetrization of a C2-symmetric diol 2.19 
through construction of pseudo-C2-symmetric heterocycle 2.20 from tripodal 
coupling of 2.19 with POCl3 and an alcohol or amine (R
3
XH, X = N, O) or a 
dichlorophosponate (X = C) to provide a conformationally controlled system 
(Scheme 6).  This system would render the previously homotopic R
1
 and R
2
 groups 
diastereotopic through a symmetry-breaking cyclization event generating a chiral, 
non-racemic bicyclic species.  Accoringly with our group's work
10
 and the 
Gouverneur group
11
 the synthesis of a P-chiral species from a prochiral P-heterocycle 
is a well-established approach. 
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 Since phosphorus is chirotopic and non-stereogenic, the construction of 2.20 
is empirically observed as a single diastereomer from 2.19 (Scheme 7).  Both possible 
approaches (2.20a and 2.20b) yield two possible chair conformations, where R
1
 is 
rendered unreactive with R
3
 in all four possibilities.  R
2
 is only reactive if it is in a 
diaxial conformation with R
3
 through a cyclization event similar to the examples 
discussed in section 2.2.1.  However, it is important to notice that both reactive 
conformers of 2.20a and 2.20b will give the same chiral, non-racemic bicyclic P-
heterocycle. 
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2.2 Results and Discussion 
2.2.1 Synthesis of Pseudo-C2-Symmetric Heterocycles 
 While this diastereoselective differentiation has been effectively displayed to 
generate [4.3.1]-bicyclic phosphate 1.26 (Scheme 9, Chapter 1),
10g
 a scope of 
different R
3
X coupling groups was investigated to determine if this differentiation 
strategy could be general.  Tripodal coupling with POCl3 and dienediol (S,S)-1.24 
provided a pseudo-C2-symmetric phosphoryl chloride, which had been previously 
reported by our group.
10g
 Various coupling partners successfully generated pseudo-
C2-symmetric phosphoramidate 2.21a and a variety of phosphates 2.21b-g (Table 1). 
Base-mediated addition of each example proved to be the highest yielding 
method.  Neutral conditions proved to lead to incomplete conversion for every 
example except for phosphonate 2.21a, which could be synthesized using DMAP and 
Et3N (68% yield) or in a one-pot procedure from (S,S)-1.24 (38% yield).  
Interestingly, phosphates 2.21c and 2.21g could not survive ambient temperature, due 
to over addition side-products arising.  This also resulted in incomplete conversion as 
well when using a 1:1 stoichiometric ratio of the phosphoryl chloride and the allylic 
alcohol. 
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Table 1 
POCl3, Et3N,
DMAP, CH2Cl2
0 ºC to r.t.
90%
Base-Mediated
Phosphorylation
OH OH O O
P
O XR
(S,S)-1.24 2.21
O O
P
O Cl
Entry XR Conditions Yield
2.21a
2.21b
2.21c
2.21d
2.21e
NH2
OH
OH
Me
OH
OH
CO2Me
Me
n-BuLi, THF
-40 ºC to rt
n-BuLi, THF
- 40 ºC to rt
n-BuLi, THF
- 40 º to 0 ºC
n-BuLi, THF
- 40 ºC to rt
NaHMDS
THF, -78 ºC
to rt
88%
75%
81%a
81%
2.21f
2.21g
OH OH
OH OTBS
n-BuLi, THF
- 40 ºC to rt 30%
b
41%a,cn-BuLi, THF- 40 º to 0 ºC
62%
aAntipode of 2.21 synthesized from (R,R)-1.24. bStatistical mixture obtained. 
cUnoptimized result.  
 P-heterocycles were also constructed from known diol (R,R)-2.9, which was 
prepared in a two-step procedure without any purification from (2S,4S)-1,5-dichloro-
2,4-petanediol (Scheme 8).
6,12
 Tripodal coupling with POCl3 followed by base-
mediated addition of allyl alcohol provided phosphate 2.22.  Phosphonate 2.23 was 
constructed in one step from vinylphosphonic dichloride
13
 in good yield.   
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 Lastly, from the (S,S)-1.24 building block, phosphonate 2.24 was synthesized 
by coupling with allylphosphonic dichloride in good yield (Scheme 9).  Overall, an 
array of pseudo-C2-symmetric P-heterocycles were constructed utilizing a similar 
protocol previously reported in our group
10g-j
 through direct and formal tripodal 
coupling with various coupling partners. 
Scheme 9 
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2.2.2 Synthesis of Chiral Non-Racemic Bicyclic P-Heterocycles 
 All of the pseudo-C2-symmetric substrates were introduced to Grubbs' second-
generation catalyst (cat-B)
14
 under refluxing solvent.  As discussed previously, 
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diastereotopic differentiation is achieved from conformational constraints, where the 
cis-conformation 2.25a is reactive and the trans-conformer 2.25b is not due to 
inadequate distance between the respective olefins (Scheme 10).   
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 Most of the P-heterocycles smoothly converted to their respective chiral, non-
racemic, P-stereogenic bicyclic products (Figure 2).   Phosphonate (S,S,SP)-2.26a
15
 
proved to be the highest yielding out of all the examples.  Phosphates (S,S,SP)-2.26b 
and (S,S,SP)-2.26c required harsher cyclization conditions due to larger ring size 
((S,S,SP)-2.26b) and higher substition (10 hours of reflux for (S,S,SP)-2.26c) to access 
those respective products.  Benzene proved to be the most effective solvent in 
obtaining (S,S,SP)-2.26d and (S,S,SP)-2.26e,
15 
contrary to the chlorinated solvents used 
in all of the other examples.  The most interesting RCM was the reaction obtaining 
phosphonate (S,S,SP)-2.26f (constructed from 2.23).
16
  This cyclization was the most 
rapid (less than 15 minutes), however longer reaction times lead to a sharp decrease 
in yield (45% yield after stirring for ~1 hour), so immediate water quenching to 
terminate catalyst activity was required to obtain formidable yields for this system. 
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 As stated before, not every pseudo-C2-symmetric P-heterocycle converted 
efficiently to its respective bicycle.  Triene 2.21c was observed to undergo complete 
conversion by TLC after 1 hour, however isolation of bicycle 2.26g was difficult 
resulting in only a trace amount of product (Scheme 11, eq 1).  Phosphate 2.21f, 
derived from two equivalents of (S,S)-1.24, required much higher catalyst loading to 
furnish 2.26h, presumably due to the free alcohol.  After isolating what appeared to 
be a single product by TLC showed a complex mixture after 
31
P NMR, which could 
be the result of promiscuous CM pathways and the alternate 9-membered ring 
formation (eq 2).  
To attempt to lower catalyst loadings and also increase the efficiency of the 
phosphorylation to 2.21g, TBS-protection of the alcohol was performed (eq 3).
17
  The 
concomitant RCM proved to decrease catalyst loadings, however after isolating what 
appeared to be a single spot by TLC revealed two compounds by 
31
P NMR analysis.  
LC-MS analysis revealed one product with the desired m/z ratio of 386, but could not 
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be confirmed to be the correct isomer since the 9-membered cyclization was also 
possible.   
Scheme 11   
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Nine-membered formation may have been negligible since phosphate 2.21c 
was subjected to very high catalyst loadings and long reaction time (>8 hours).  When 
attempting at higher temperature (90 ºC in DCE) no improvements were made and 
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starting material was observed along with a second product by TLC of higher 
polarity.  Isolation of the second product was achieved, however only a trace amount 
of what appeared to be the 9-membered cyclization was obtainable.
18
 It seems from 
these studies that obtaining larger ring sizes than 8 could prove to be the threshold for 
constructing these chiral, non-racemic bicyclic P-heterocycles. 
2.3 Conclusions 
 A general protcol was established by expanding from the reported chiral, non-
racemic bicylic P-heterocycles.
10 
The diastereotopic differentiation of C2-symmetric, 
1,3-anti-diol builing blocks, both antipodes of 1.24 and (R,R)-2.9, is the key step in 
developing a terminus differention, chain elongation strategy.
2 
Future directions of 
this project would entail the study of potential reactivity patterns shown from 
phosphates (R,R,RP)- and (S,S,SP)-1.26, (S,S,SP)-1.36,
10g
 and (R,R,RP)-1.44
10i
 in olefin 
metathesis and regioselective transformations (e.g. hydroboration, olefin reduction, 
etc.) of the variety of systems made (Figure 3).  Ideally, this study will expand the 
scope of polyol subunits synthesized via P-heterocyclic templates to apply toward the 
facile construction biologically active natural products. 
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Chapter 3 
Phosphate Mediated Construction of the C15-C30 
Subunit and Total Synthesis of Dolabelide C 
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3.1. Introduction 
3.1.1 Isolation and Bioactivity of Dolabelide C 
In 1995, the isolation and structural characterization of two new 22-membered 
macrolides, dolabelides A and B, from the sea hare Dolabella auricularia was 
reported (Figure 1).
1
  These compounds exhibited cytotoxicity against cervical cancer 
HeLa-S3 cells with IC50 values of 6.3 and 1.3 µg/mL, respectively.  Two years later, 
dolabelides C and D,
2
 24-membered macrolides, were isolated from the same source 
and were found to possess cytotoxicity toward HeLa-S3 cells with IC50 values of 1.9, 
and 1.5 µg/mL, respectively.  To the best of our knowledge, the mechanism of action 
of these compounds remains unknown to date. 
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Figure 1 
Common features among the dolabelide family are 11 stereogenic centers, 8 
of which bear oxygen, and two E-configured trisubstituted olefins.  Other attributes 
possessed by this family of macrolactones include 1,3-anti-diol fragments found at 
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C7/C9 and C19/C21, along with an accompanying 1,3-syn-diol at C9/C11 and 
polypropionate fragments at C1/C4 and C21/C23.  The stereochemical complexity 
and biological profile of this class of compounds has attracted synthetic interest from 
several groups
3
 and in 2006, the total synthesis of dolabelide D was reported by 
Leighton and coworkers.
4
 
3.1.2 Synthetic Approaches Toward Dolabelide Family 
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Along with the Leighton group, there have been other efforts concentrated 
toward the dolabelide family (Figure 2).  Keck and McLaws synthesized the C1-C13 
subunit first starting from a fragment bearing the C1/C3/C4 stereochemistry (derived 
from benzyl-protected Roche's ester).
5
 The C7 stereocenter was generated through a 
reagent-controlled methallylation with tributylmethallylstannane, followed by 
manipulation to a ketone, which was reacted with acryolein providing 1,5-
stereoinduction6 from the C7 center setting the C11 carbinol (Figure 2, eq 1).  Finally, 
the C9 center was set through a stereoselective 1,3-anti-reduction7 giving the C1-C13 
subunit. 
  Prunet and coworkers devised a synthesis of the C1-C15 subunit of dolabelide 
C where the C9 and C11 stereocenters were constructed through a conjugate addition 
giving a benzylidene acetal, which was converted to an aldehyde bearing the requisite 
C8-C14 framework (Figure 2, eq 2).  A Mukiyama aldol,8 which a silyl enol ether 
bearing the necessary C2-C4 stereochemistry furnishing the C1-C14 fragment.9  The 
C14 benzyl ether was then converted to a ketone, which was homologated and 
converted to a Z-substituted vinyl-iodide via CM and iodination. 
A route to the C15-C30 subunit of dolabelide A was realized by Phansavath, 
Genet and coworkers (Figure 2, eq 3), where sequential Ru-mediated hydrogenation 
of !-keto esters was employed to generate the required stereochemistry of the C19 
and C21 stereocenters.10 A lithium-vinylate addition completed the C15-C30 
framework, where an oxidation/reduction sequence was required to stereoselectively 
generate the C23 carbinol. 
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3.2 Results and Discussion 
3.2.1 Retrosynthetic Analysis of Dolabelide C 
From a synthetic perspective, dolabelide C (3.1) can be retrosynthetically 
disconnected into C1-C14 and C15-C30 subunits, 3.5 and 3.7, respectively (Scheme 
1).
11
  The endgame for this approach is similar to Leighton’s strategy towards 
dolabelide D,4 employing a macrocyclization sequence to install the C14/C15 
trisubstituted olefin through a late stage ring-closing metathesis (RCM) reaction.  
Macrocyclization is preceded by Yamaguchi coupling between the C1 carboxylic acid 
and the C23 carbinol center contained within the advanced subunits 3.5 and 3.7, 
respectively. Central to our synthetic approach are the 1,3 anti-diol motifs at the 7,9 
and 19,21 carbinol carbons assembled and functionalized from bicyclic phosphates 
(R,R,RP) and (S,S,SP)-3.3. 
The development of a formal diastereotopic differentiation strategy of C2-
symmetric diols (R,R) and (S,S)-3.2 through phosphate tethers allowed us to envision 
access to both 3.5 and 3.7.
12
 Using the salient features of both antipodes of bicyclic 
phosphate 3.3, the utilization of regioselective cross-metathesis and olefin reduction 
would allow significant elaboration to appending the C1-C6 and C15-C18 segments 
of 3.5 and 3.7.  Our progress on SN2' displacements of cyclic allylic phosphates
13 
persuaded us to envisage a Pd(0)-mediatied formate reduction of 3.3 to facilitate the 
generation of the C11-C14 portion of 3.5 and a cuprate addition to install the C22 
methyl group of aldehyde 3.6, which could furnish 3.7 by a vinyl-metallate coupling 
and subsequent transformation to construct the C15 terminal olefin. 
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3.2.2 Modification to Synthesis of C15-C30 Subunit 
Previous reports showed the possibility of a phosphate-mediated route toward 
3.1, where the carbon framework of both 3.5 and 3.7 were realized (as shown in 
Chapter 1).
14,15
 While the phosphate methodology proved to be a viable proof of 
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concept, attempts to remove one, two, or all three MOM-protecting groups from 3.8 
proved problematic as all conditions tested for cleavage of these groups in the 
presence of the more labile TIPS-protecting groups provided unreacted starting 
material or total decomposition of the substrate (Scheme 2).  The difficulty in 
removing these protecting groups to reveal either the C21 carbinol (access to 
dolabelide A) or C23 carbinol (access to dolabelide C) prompted a reevaluation of 
protecting groups to access a suitable C15-C30 subunit of dolabelide.  
Scheme 2 
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The new approach sought to introduce the C23 carbinol in a late stage vinylate 
addition, where the terminal C15 olefin would already be intact.  Also, a new 
protecting scheme was crucial for deprotection manipulation at the end of the total 
synthesis of dolabelide C.  This route commenced from (S,S,SP)-3.3, employing 
similar chemistry previously shown to diol 3.11 (also shown in Chapter 1).
15
 With the 
established 1,3,4-anti,anti-stereotetrad installed, acetonide protection, oxidative 
cleavage and hydride reduction of the newly formed aldehyde to its resultant primary 
alcohol (3.12) was performed over 3 steps (Scheme 3).  Silylation (TBSCl), 
debenzylation under hydrogenation conditions and iodination/elimination of the 
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concomitant primary alcohol to its respective terminal olefin was finally desilylated 
to give intermediate 3.13. 
Scheme 3  
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With alcohol 3.13 in hand, Swern oxidation
16
 provided aldehyde 3.14, which 
was subjected to vinylate addition from vinyl iodide 3.15, bearing a TES protecting 
group instead of the previously utilized MOM group (see Chapter 1).  The addition 
resulted in a separable mixture of epimers in a 1:1 dr in 79% yield (Scheme 4).
17
  The 
undesired epimer was recycled through an oxidation/reduction protocol first with 
Dess-Martin periodinane (85% yield) and hydride reduction (see Table in Scheme 4).  
Using the previously reported conditions by Mori (LiAlH4, LiI)
18
 resulted in a 
generation of the undesired epimer as the major product (1:1.5 dr).  However, other 
reagents, L-selectride, (S)-CBS
19
 and NaBH4 all gave favorable ratios for the desired 
epimer, affording a suitable protocol for recycling the undesired epimer.  This route 
72 
yielded a fragment suitable for acid coupling with the C1-C14 subunit, with the C23 
carbinol available. 
Scheme 4 
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3.2.3 Final Stages to Total Synthesis of Dolabelide C 
  With both subunits of dolabelide C successfully synthesized, studies toward 
the completion of dolabelide C began (Scheme 5).  This process commenced with the 
complete acetylation of previously reported triol 3.1714 to install the proper 
acetylation pattern for C1-C14 subunit of dolabelide C (Scheme 5).  This was 
accomplished by adding acetic anhydride and pyridine to triol 3.17 to afford triacetate 
3.18 in excellent yield.  Deprotection of the TBS protecting group provided alcohol 
3.19 in 93% yield.  Swern oxidation of 3.19 generated the desired aldehyde that was 
prone to epimerization and was taken on without purification.  Pinnick oxidation of 
the aldehyde provided carboxylic acid 3.20 in 81% yield over the two-step sequence, 
which was ready for coupling with the C15-C30 subunit.   
73 
Scheme 5 
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 Final coupling of the C1-C14 carboxylic acid 3.20 and the C15-C30 alcohol 
3.16 was achieved using Yamaguchi conditions,20 as previously described by 
Leighton and coworkers (Scheme 6).4 The addition of 2,4,6-trichlorobenzoyl chloride, 
Et3N, and DMAP at -78 ºC for 21 hours avoided epimerization at C2 and yielded the 
desired coupled 3.21 in 77% yield.  Deprotection of the C27-TES protecting group 
was achieved with TBAF in 94% yield.  Subsequent acylation provided 3.22 in 98% 
yield.  The final two protecting groups were removed using PPTS in MeOH, followed 
by treatment with DDQ to provide metathesis precursor 3.23 in excellent yield over 
two steps.  Efforts to close the ring were attempted prior to PMB ether removal and 
provided the desired RCM product as observed by HRMS, albeit in poor overall 
conversion. As a result, subsequent investigations focused on RCM of the deprotected 
triol 3.23.  Portion-wise addition of 20 mol % of cat-B] to triol 3.23 afforded 
approximately a 1:1 E/Z mixture of dolabelide C 3.1 in a 57% yield.   
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3.3 Conclusions 
 The total synthesis of dolabelide C was completed in 0.73% overall yield from 
2,4-pentanedione utilizing a phosphate-mediated approach toward the two 1,3-anti-
diol subunits embedded within the 24-membered macrocycle's construct.  To the best 
of our knowledge this is the first total synthesis of a natural product utilizing a 
temporary phosphate tether.  While first efforts toward the C15-C30 subunit 
encountered difficulty with the protecting group strategy, a solution was found by 
introducing the C23 carbinol in the last step of the sequence via vinylate addition.  
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Both subunits were obtained in 13-step routes starting from their respective antipodes 
of phosphate 3.3 and the longest linear sequence from commercially available 
material, 2,4-pentanedione,
21
 was 27 steps and the total synthetic steps required from 
both antipodes of the readily available 1,5-dichloro-2,4-petanediol were 51.
22
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Chapter 4 
Study of Isomerization/Ring-Closing Metathesis 
Side Reaction and Scale Up of Dolabelide C 
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4.1 Introduction 
4.1.1 Purification Attempts of Final Mixture of E:Z Diastereomers 
 After constructing the 24-membered lactone of dolabelide C by RCM, flash 
chromatography was performed on the final mixture of E:Z diastereomers to obtain a 
pure sample of the naturally occurring E-isomer (Scheme 1).  Based on the premise of 
the Leighton group's reported protocol to obtain a pure sample for NMR analysis of 
their 1.3:1 mixture of E:Z diastereomers,
1
 multiple successive attempts of employing 
normal-phase flash column chromatography from what was a 3.0 mg mixture did not 
afford a pure enough sample for suitable 
1
H and 
13
C NMR analysis. 
 Scheme 1 
3.1
Dolabelide C
OAc
Me
OH OH
Me
O
OAc OAc
Me
OH
Me
O
Me
n-Pr
OAc
14
OAc
Me
OH OH
Me
O
OAc OAc
Me
OH
Me
O
Me
n-Pr
OAc
3.23
cat-B (20 mol %)
CH2Cl2, 0.5 µM
57% yield
~1:1 E:Z ratio
15
4.1
Unnatural
C14-C15 Z-isomer
Me
OAc OAc
Me
OH
Me
OOAc
Me
OH MeHO
n-Pr
OAc
O
 
80 
 What was perplexing was the fact that the Z-isomer appeared to be completely 
separated from the original mixture (see TLC plate in Figure 1).  After spotting the 
isolated Z-isomer (left side of the TLC plate) against the E-isomer, it appeared they 
were separating cleanly from one another.  The other concern at this stage was the 
amount of material available through the numerous attempts at purification, which 
could have led to insufficient material for ample resolution in the NMR experiements. 
 
E
Z
E
Z
 
Figure 1. TLC analysis after separating E:Z diastereomers of 3.1 from flash 
chromatography.  Left side of both plates indicate the Z-diastereomer and the right 
side of each plate the assumed pure E-isomer (dolabelide C). 
 While there was still a significant amount of impurity, the resonances from the 
isolation paper of dolabelide C
2
 were identifiable in the 
1
H NMR spectrum (Figure 2).  
Based on peak assignments in the data shown and also HRMS evidence the natural 
isomer exists within this mixture, an analytical approach was taken to identify a 
proper means of purifying the end product.  
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Figure 2.  NMR analysis of E-isomer with all assigned resonances correlating with 
the 1997 isolation paper.
2
 The top spectrum shows the whole region and bottom the 
acetate region.  
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 Analytical runs of the mixture on LC-MS analysis
3
 sought to achieve an 
acceptable method to separate the unwanted by-product(s), which was mainly 
presumed to be the C14-C15 Z-diastereomer.  However, after obtaining the total-ion 
chromatograph (TIC) from developing exquisite separation of the components 
existing in the mixture, the major by-product was not the presumed Z-diastereomer 
(Figure 3).  Fortunately the major peak of in the TIC was assumed to be the natural E-
isomer (m/z 797.5 (+H)
+
) the second most abundant peak was 14 m/z units or a 
methylene group (-CH2-) away from dolabelide C.  
Dola C 4:1 analytical test run 10mm Zorbax C18 Col
Time
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00
%
2
U011504 Scan ES+ 
TIC
7.01e8
21.66
16.80
8.28
0.62 1.35
15.0912.66
10.96 18.99
 
m/z 797.5 (+H)+
m/z 814.5 (+NH4)
+
m/z 819.4 (+Na)+
m/z 783.4 (+H)+
m/z 800.5 (+NH4)
+
m/z 805.3 (+Na)+
m/z 769.3 (+H)+
m/z 786.4 (+NH4)
+
m/z 791.4 (+Na)+
Dolabelide C
calculated MW = 797.0240
exact mass = 796.4973
-14 m/z (-CH2)
-28 m/z (-CH2CH2)
m/z 797.5 (+H)+
m/z 814.5 (+NH4)
+
m/z 819.4 (+Na)+
 
Figure 3.  LC-MS analysis of mixture obtained after successive flash 
chromatography of 3.1. Peak at 21.66 matches with 3.1 however other major peaks 
are 22- and 23-membered macrolides contaminating the final product. 
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Two additional abundant peaks in the mixture were 28 m/z units or two 
methylene units away (-C2H6-) from the desired E-isomer.  While it was not clear at 
the time, what these products were and their respective side-reactions, it was 
confirmed that one of the olefinic diastereomers, which we presumed to be the Z-
isomer, was being removed effectively by normal-phase flash chromatography. 
4.2 Isomerization/Ring-Closing Metathesis 
4.2.1 Isomerization/RCM Side Reaction in Synthesis of Medium-Sized Rings 
 To determine the cause of the side products from the RCM of the 24-
membered lactone, reports of the synthesis of medium and large ring sizes were 
surveyed.  In 1997, Clark and Kettle observed in their intentions to constructing 6,8-
bicycle 4.3 from pyran 4.2, a considerable amount of 6,7-bicycle 4.4 was produced in 
a 2:1 ratio using Schrock's catalyst,
4
 cat-D (Scheme 2).
5
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 In the same year, Overman and Joe encountered a similar problem, where 
compound 4.5 was subjected to 1 equiv. of cat-D in dilute conditions (C6D6 at 0.05 
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M) providing 4.6, which lost a methylene group from their desired 9-membered ring 
(Scheme 3).
6
  It was presumed 4.5 was going through an isomerization event prior to 
ring closure, resulting in a net loss of an extra methylene unit.   
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 This side process was first reported with Grubb's catalyst by Hoye and Promo 
in their studies of metathesizing silicon-tethered alkenols (Scheme 4).
7
 Silaketal 4.7 
was introduced to a catalytic amount of cat-A (10 mol %) where aliquots were taken 
out after 50% conversion (determined by GC-MS).  
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Analysis showed the appearance of expected cyclic silaketal 4.8, along with 
heterocycles 4.10 and 4.11, which were one and two methylene units away, 
respectively.  What is also key to note from this result is the isomerization of 4.8 to 
4.9 after RCM.  It was suggested a ruthenium hydride species could be the culprit of 
these deleterious side reactions.
7
  
4.2.2 Evidence of Ru-Hydride Species from Grubbs' Complexes 
 In 2002, Grubbs and Louie isolated the first Ru-hydride species as a 
decomposition product from generating a Ru Fischer-type carbene 4.12 by reacting 
cat-A with ethyl vinyl ether (Scheme 5).
8
 By heating carbene 4.12 to 80 ºC in 
benzene, evidence of Ru-H bond was determined by NMR analysis and X-Ray 
crystallography later confirmed this to be complex 4.13. 
Scheme 5 
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 It was later shown that heating cat-A various primary alcohols also induced 
decomposition to Ru-hydride 4.13.
9
 Dinger and Mol proposed a mechanism of 
degradation first through dissociation of one of the phosphine ligands followed by 
coordination of the methanol to ruthenium (4.14) (Scheme 6).  Elimination of 
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chloride would have a methoxy-ruthenium species (4.15) that would first deliver a 
hydride to the Ru-carbene (4.16) and then eliminate toluene to Ru-formate 4.17.  Ru-
hydride formation then occurs through a final hydride delivery from the formyl ligand 
and phosphine ligation to 4.13. This phenomenon has also been observed with 
Grubbs' second-generation catalyst (cat-B) by metathesizing ethyl vinyl ether to form 
the ensuing Ru-alkylidene.
10
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4.3 Results and Discussion 
4.3.1 Identification of Isomerization/RCM By-Products 
  Based on the literature reports of isomerization/RCM side products and LC-
MS analysis, it was concluded this side process was the cause for the complex 
mixture from the final step in the synthesis of dolabelide C (Scheme 7).  In light of 
these facts, intermediates 3.23a and 3.24b would be likely candidates for the by-
products containing one and two less methylene units, respectively.    
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 The other by-product (4.18) mirroring the m/z ratio (Figure 4) is presumed to 
arise from an isomerization event occurring after RCM, since the Z-isomer was 
removed via flash chromatography.
11
 Other macrocycles formed in the reaction 
mixture are potentially 4.19 (occurring from 3.23a), 4.20 (occurring from 3.23b) and 
4.21.  Another potential isomerization/RCM could occur from the tri-substituted 
olefin, forming a 1,1-dimethyl substituted olefin.  However, to the best of our 
knowledge, an RCM under identical conditions has not been reported, therefore this 
pathway is not being proposed.
12
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Figure 4.  LC-MS peak assignments of major by-products observed from final RCM 
mixture. 
4.3.2 Scale Up Efforts of Developed Route to Dolabelide C 
 Given the excellent separation shown from the TIC in Figure 4, semi-
preparative LC-MS was performed to isolate the peak representing dolabelide C (3.1).  
However, the small amount of material available from the beginning of the 
purification did not provide ample material for a well resolved 
1
H NMR.  Therefore, a 
scale up of the route developed in Chapter 3 was performed to provide more of 
dolabelide C for full characterization.
13
  
Both syntheses to each subunit proved to be scalable, providing 300 mg of 
3.16 (from (S,S,SP)-3.3) and 175 mg of 3.20 (from (R,R,RP)-3.3).  This material was 
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carried through the same endgame steps (Scheme 8) affording 160 mg of RCM 
precursor 3.23 to apply towards the goal of optimizing the C14/15 E:Z ratio and 
minimizing the amount of deleterious side reactions occurring in the final RCM step. 
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4.3.3 Optimization Studies on Final RCM Step 
 The copious amount of 3.23 available allowed for a thorough evalulation for 
the optimization of the final RCM step.  It was first studied on microgram scale by 
preparing solutions of metathesis catalysts and adding them to a refluxing mixture of 
3.23.  First the conditions used in the reported final step were attempted to be 
reproduced, however conversion drastically decreased by using the catalyst in a 
solution of its respective solvent (entries 1-3 in Table 1).  However, by scaling up to 
milligram scale and adding in neat cat-B (entry 4) complete conversion was achieved, 
reproducing the earlier result.  Trying to use Hoveyda-Grubbs second geneation (cat-
90 
C) catalyst on this system proved ineffective for using it as a solution (entry 5) and 
also neat in milligram scale (entry 6). 
Table 1 
Catalyst
cat-B
cat-B
cat-B
cat-B
cat-C
cat-C
Solvent
CH2Cl2
PhCH3
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
Time
> 12 h
> 12 h
> 12 h
6 h
>12 h
>12 h
Conversion
10%
0%
5%
100%
0%
0%
Conc. of
Cat. Solution Total Loading
25 mol %
25 mol %
25 mol %
25 mol %
25 mol %
25 mol %
0.3 mg/mL
0.3 mg/mL
0.6 mg/mL
neat
0.3 mg/mL
neat
Entry
1
2
3
4
5
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 Now that the original conditions were reproduced, a screening of different 
metathesis catalysts bearing phosphine and NHC ligands
14
 was done (since cat-C was 
ineffective, only phosphine-bearing catalysts were desired in this study).  These 
catalysts were presumed to exhibit higher activity than cat-B and were shown to 
metathesize N,N-diallylbenzenesulfonamide at room temperature.   
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 Through the developed method on LC-MS, the results in Table 2 were 
determined by integrating underneath the peak areas from the TIC.  One important 
modification to the RCM protocol for this screening was the preparation of solvent.  
Each reaction was run in non-stabilized CH2Cl2 that was passed through a purification 
system employing activated Al2O3,
15
 then distilled over CaH2 and finally degassed 
utilizing the freeze-thaw technique with a Schlenk system.  This protocol was used in 
the conditions reported in Chapter 3 (entry 1, Table 2) giving nearly complete 
conversion, a 1:1 E:Z ratio of diastereomers and about 8% of the overall mixture 
consisted of by-products arising from Ru-hydride side reactions.   
Table 2 
Entry
1
2a
3
4
5
Catalyst
cat-B
cat-B
cat-E
cat-F
cat-G
Conversionb
>99%
87%
100%
100%
87%
E:Zb
1:1
1.2:1
1:1
1:1.1
1.2:1
E:Z:By-Pdtsb
1:1:0.17
1.2:1:0.26
1:1:0.80
1:1.1:0.45
1.2:1:0.61
aPurified newly purchased catalyst through SiO2 plug in 10:1 hexanes:ethyl acetate.
bConversion and product ratios were determined from crude LC-MS analysis.  
 Eluding cat-B through a short plug of SiO2 in hexanes:ethyl acetate (10:1 
ratio) gave a slight increase in E:Z ratio, but provided a decrease in conversion and 
delivered a higher percentage of by-products (entry 2).  In screening the new 
catalysts, cat-E (entry 3) and cat-F (entry 4) gave complete conversion of starting 
material, but also provided a higher percentage of by-products.  Lastly, cat-G proved 
inefficient in comparision to cat-B as well, yielding a significantly higher 
percentage
16
 of by-products along with incomplete conversion (entry 5). 
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4.3.4 Scale Up of Final RCM and Isolation of Natural and Non-Natural Isomers 
 Even though the optimization study did not provide a better candidate for 
reaction scale up of the final RCM step, the ability to scale the overall process to 
yield 160 mg of RCM precursor 3.23 was a great proof of concept that this synthesis 
can provide ample quantities for purification with the knowledge gained of Ru-
hydride by-products.  The last step was run on 70 mg scale furnishing another 
mixture of E:Z diastereomers and Ru-hydride by-products (Scheme 9). 
Scheme 9 
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 After screening potential solvent systems to isolate both the natural isomer 3.1 
and the non-natural isomer 4.1, it was determined running the mixture through two 
successive normal-phase, flash columns (one through CH2Cl2:acetone 8:1, and the 
second through pentane:ethyl acetate 5:1) could provide both isomers analytically 
93 
pure.  Gratifyingly, the developed protocol provided 14 mg of analytically pure 
dolablide C (Figure 6). 
 
Figure 6. Analytically pure sample of dolablide C (3.1) from LC-MS analysis. 
 Accordingly, the sample was submitted for 
1
H NMR analysis, which showed 
all of the resonances reported in the isolation paper
2
 and no significant amount of by-
products (Figure 7).  Overall, this reaction gave a 24% yield from the final scale up of 
the synthesis and also gave 10 mg of the non-natural Z-isomer, which was also fully 
characterized.
13
 These compounds will be submitted to the National Cancer Institute 
for 60-cell testing of each compound and also a head-to-head comparison of the two 
isomers.
17
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Figure 7.  Top spectrum shows NMR analysis of an analytically pure sample of 
dolabelide C in pyridine-d5 and the bottom spectrum is an expanded view from ! 1.0-
2.5. 
95 
4.4 Conclusion 
 Dolabelide C and its non-natural C14-C15 Z-diastereomer were produced and 
isolated from a scalable phosphate-mediated synthesis.  A complex mixture was 
generated in the final RCM step resulting in by-products, which arose from a net loss 
of CH2 and C2H6, that proved to be inseparable through repeated flash 
chromatography (8:1 CH2Cl2:acetone).  Since the material produced at the end of the 
first synthesis of 3.1 was sparse, a re-synthesis provided 175 mg of the C1-C14 
subunit (3.20), 300 mg of the C15-C30 subunit (3.16) and 160 mg of RCM precursor 
3.23.  This allowed a detailed optimization study through a screening of various 
metathesis catalysts, concluding with the originally developed conditions in Chapter 3 
provided the optimum results.  Overall, 14 mg of dolabelide C and 10 mg of the Z-
isomer (4.1) were produced and their biological activities will be further evaluated by 
the National Cancer Institute for 60-cell testing of each compound and also a head-to-
head comparison of the two isomers.
17
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General Experimental Methods 
 All air and moisture sensitive reactions were carried out in flame- or oven-dried glassware 
under argon atmosphere using standard gastight syringes, canellas, and septa.  Stirring was 
achieved with oven-dried, magnetic stir bars.  Et2O, toluene, THF and CH2Cl2 were purified by 
passage through a purification system employing activated Al2O3 (Grubbs, R. H.; Rosen, R. K.; 
Timmers, F. J. Organometallics 1996, 15, 1518-1520).  Et3N was purified by passage over basic 
alumina and stored over KOH.  Flash column chromatography was performed with SiO2 (Silica 
Gel 60Å, 40-63 um) and thin layer chromatography was performed on silica gel 60F254 plates 
(both purchased from Sorbent Technologies). 1H were collected at resonance frequencies of 400 
MHz, 100 MHz, and 162 MHz and 13C NMR spectra at 500 MHz and 125 MHz respectively.  
High-resolution mass spectrometry (HRMS) and FAB spectra were obtained on a double-
focusing mass spectrometer.  HPLC-MS analysis was developed with a Waters 2695 HPLC 
system on a SiliChromTM XDB C18 reverse phase column (4.6 mm I.D. x 200 mm) and detected 
on an AUTOSPEC-Q tandem mass spectrometer. 
100 
(4R,6R)-nona-1,8-diene-4,6-diol: 2.9 
OH OH
ClCl
OH OH 1) KOH, 0 ºC to RT
2) VinylMgBr, CuI
-78 ºC to -20 ºC
(R,R)-2.9  
 (2S,4S)-1,5-dichloro-2,4-pentanediol
1
 (1.2 g, 6.9 mmol) was taken up in Et2O (69 mL) and 
cooled to 0 ºC.  Crushed KOH was added in portions to the cold solution over 5 minutes.  The 
reaction was allowed to warm back to RT.  After 3 hours (disappearance of SM observed by GC 
analysis) the clear solution was filtered through MgSO4 and rinsed with a minimal amount of dry 
Et2O.  This solution was then placed under an argon atmosphere.  CuI (533 mg, 2.8 mmol) was 
added and the solution was stirred at RT for about 10 minutes.  After cooled to -78 ºC, a freshly 
prepared 1.0 M of vinylmagnesium bromide in THF (28 mL, 28 mmol) was added dropwise over 
10 minutes.  The resulting brown colored solution was allowed to warm slowly to -20 ºC in the 
cold bath.  After 2.5 hours, the solution was quenched slowly with NH4Cl (25 mL) at -20 ºC and 
was allowed to warm to RT.  The resulting suspension was filtered through celite to remove any 
solids forming from the quenching process.  The layers were partitioned with H2O and Et2O and 
the aqueous layer was extracted with Et2O (3 x 50 mL).  The collected organics were washed 
with brine (25 mL), dried with Na2SO4 and filtered.  The filtrate was concentrated providing 
(R,R)-2.9 as a yellow oil (674 mg, 62% yield over 2 steps).   
[!]D -12.4 (c = 0.50, CH2Cl2); 
FTIR (neat) 3352.05, 3076.25, 3002.96, 2977.89, 2935.46, 1976.90, 1641.31, 1433.01, 1326.93, 
1220.86, 1135.99, 1049.20, 995.20, 914.20, 871.76, 831.26 cm
-1
; 
                                                
1
 Readily available from 2,4-pentanediol: Rychnovsky, S. D.; Griesgraber, G.; Powers, J. P. Org. 
Syn. 2000, 77, 1-6. 
101 
1
H NMR (CDCl3, 500 MHz)
2
 " ppm 5.87-5.77 (m, 2H), 5.19-5.12 (m, 4H), 4.03-3.97 (m, 2H), 
2.45-2.35 (m, 2H), 2.32-2.22 (m, 4H), 1.65 (t, J = 6.2 Hz, 2H); 
13
C NMR (CDCl3, 125 MHz) " ppm 134.6 (2), 118.3 (2), 68.1 (2), 42.0 (2), 41.5; 
HRMS calculated for C9H16O2 (M+NH4)
+
 174.1494; found 174.1466 (ESI). 
                                                
2
 Peak at " 2.04 is presumed to be a H2O peak, which was difficult to remove. 
102 
(4R,6R)-4,6-diallyl-2-chloro-1,3,2-dioxaphosphinane 2-oxide: S1 
OH OH POCl3, Et3N
DMAP, 0 ºC
O O
P
O Cl
(R,R)-2.9 S1  
 Diol 2.9 (98 mg, 0.627 mmol) was taken up in CH2Cl2 (3.14 mL) at RT.  Triethylamine 
(0.393 mL, 2.82 mmol) and DMAP (7.66 mg, 0.0627 mmol) were added sequentially.  After 
cooling the mixture to 0 ºC, freshly distilled POCl3 (0.088 mL, 0.941 mmol) was added dropwise 
resulting in a white suspension (from formation of amine salts).  After 10 minutes, 2.9 was 
consumed (determined by TLC analysis) and the suspension was diluted with Et2O (5 mL) to 
crash out remaining amine salts.  The mixture was filtered through a fritted funnel and rinsed 
thoroughly with Et2O (20 mL).  The filtrate was concentrated under reduced pressure and 
purified through a plug of SiO2 in 2:1, hexanes:EtOAc.  The collected fractions were 
concentrated under reduced pressure affording a yellow oil (133 mg, 90% yield). 
[!]D +39.1 (c = 0.45, CH2Cl2); 
FTIR (neat) 3080.11, 2923.88, 2491.86, 2453.29, 1641.31, 1303.79, 1087.78, 1027.99, 981.70, 
921.91 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) " ppm 5.70-5.82 (m, 2H), 5.17-5.23 (m, 4H), 4.68-4.82 (m, 2H), 
2.78-2.85 (m, 1H), 2.41-2.62 (m, 3H), 2.15 (ddd, J = 14.9, 9.1, 5.3 Hz, 1H), 2.02 (ddd, J = 15.0, 
5.9, 3.6 Hz, 1H
3
);  
13
C NMR (CDCl3, 125 MHz) " ppm 131.7, 131.2, 119.7, 119.6, 81.0 (d, JC-P = 9.0 Hz), 77.1 (d, 
JC-P = 7.8 Hz), 39.7 (d, JC-P = 9.3 Hz), 38.1 (d, JC-P = 2.2 Hz), 32.2 (d, JC-P = 8.1 Hz); 
31
P NMR (162 MHz, CDCl3) " ppm -3.84; 
                                                
3
 Water peak at " 2.04 zeroed out to give a ddd, 1H signal. 
103 
HRMS calculated for C9H14ClO3P (M+Na)
+
 259.0267; found 259.0274 (ESI).
104 
(3R, 5R)-5-((tert-butyldimethylsilyl)oxy)hepta-1,6-dien-3-ol: S2 
OH OH OH OTBS
t-BuOK
TBSCl
(R,R)-1.24 S2  
 To a suspension of t-BuOK (57 mg, 0.504 mmol) in THF (1.01 mL) was added a solution of 
diol (R,R)-1.24 (61 mg, 0.480 mmol) in THF (0.240 mL), dropwise.  After stirring 45 minutes at 
RT, TBSCl (76 mg, 0.504 mmol) was added portion-wise.  The reaction was stirred for 16 hours 
at RT and quenched with about 5-10 drops of 10% aq. K2CO3 (until suspension broke up).  
Anhydrous Na2SO4 was added directly to the mixture and filtered.  The filtrate was concentrated 
under reduced pressure and purified via flash chromatography in 20:1, hexanes:EtOAc.  Product 
S2 was obtained as a yellow oil (60 mg, 52% yield) along with recovered starting material (12 
mg, 65% BRSM). 
[!]D -13.5 (c = 0.20, CH2Cl2); 
FTIR (neat) 3421.48, 2954.74, 2927.74, 2856.38, 2358.78, 2341.42, 1652.88, 1253.64, 1072.35, 
837.05, 777.26 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) " ppm 5.86 (dtd, J = 17.1, 10.3, 5.6 Hz, 2H), 5.25 (dtd, J = 17.2, 
4.8, 1.6 Hz, 2H), 5.11 (ddt, J = 25.5, 10.5, 1.5 Hz, 2H), 4.48-4.52 (m, 1H), 4.40 (br s, 1H), 3.28 
(s, 1H), 1.66-1.78 (m, 2H), 0.92 (s, 9H), 0.08 (d, J = 17.2 Hz, 6H); 
13
C NMR (CDCl3, 125 MHz) " ppm 140.9, 140.1, 114.7, 113.9, 72.3, 69.6, 43.1, 25.8 (3), 18.1,  
-4.5, -5.1; 
HRMS calculated for C13H26O2Si (M+Na)
+
 265.1600; found 265.1592 (ESI). 
105 
(4S,6S)-2-(allylamino)-4,6-divinyl-1,3,2-dioxaphosphinane 2-oxide: 2.21a 
NH
P
O
O
O
Cl
P
O
O
O
NH2
n-BuLi
-60 ºC to -30 ºC
2.21a  
 Allylamine (0.13 mL, 0.176 mmol) was taken up in THF (0.881 mL) and cooled to -60 ºC.  
Dropwise addition of n-butyllithium (0.70 mL, 2.4 M solution in hexanes) afforded a yellow 
solution that was stirred for about 10 minutes at -60 ºC.  A solution of (4S,6S)-2-chloro-4,6-
divinyl-1,3,2-dioxaphosphinane 2-oxide4 (35 mg, 0.168 mmol) in THF (0.336 mL) was delivered 
dropwise via cannulation.  The reaction was allowed to warm slowly in the cold bath to -30 ºC.  
After 35 minutes, TLC analysis showed consumption of the starting material.  The solution was 
quenched at -30 ºC with NH4Cl (1 mL) and was warmed to RT.  After partitioning with H2O (5 
mL) and EtOAc (5 mL), the aqueous layer was extracted with EtOAc (3 x 5 mL).  The collected 
organics were washed once with brine (5 mL), dried with Na2SO4 and filtered.  Filtrate was 
concentrated under reduced pressure and purified using flash chromatography (2:1, 
hexanes:EtOAc).  Concentration of the collected fractions under reduced pressure provided 
2.21a as a yellow oil (34 mg, 88% yield). 
[!]D +67.4 (c = 0.38, CH2Cl2); 
FTIR (neat) 3207.40, 2985.60, 2931.60, 2856.38, 1645.17, 1614.31, 1514.02, 1442.66, 1377.08, 
1245.93, 1224.71, 1110.92, 1027.99, 995.20, 927.70 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) " ppm 6.12 (ddd, J = 16.7, 10.7, 5.8 Hz, 1H), 5.87 (ddddd, J = 
17.3, 10.7, 5.3, 3.1, 1.7 Hz, 2H), 5.20-5.50 (m, 5H), 5.07-5.13 (m, 2H), 4.90-4.97 (m, 1H), 3.52-
3.59 (m, 2H), 2.93-3.00 (m, 1H), 2.08-2.15 (m, 1H), 1.98-2.07 (m, 1H); 
                                                
4
 Synthesis reported in earlier publication: Whitehead, A.; McReynolds, M. D.; Moore, J. D.; 
Hanson, P. R. Org. Lett. 2005, 7, 3375-3378. 
106 
13
C NMR (CDCl3, 125 MHz) " ppm 135.8 (d, JC-P = 1.9 Hz), 135.8, 135.7 (d, JC-P = 2.1 Hz), 
117.9, 116.9, 115.7, 77.4 (d, JC-P = 6.1 Hz), 73.8 (d, JC-P = 4.9 Hz), 44.0, 35.3 (d, JC-P = 7.5 Hz); 
31
P NMR (162 MHz, CDCl3) " ppm 3.58; 
HRMS calculated for C10H16NO3P (M+Na)
+ 252.0766; found 252.0739 (ESI). 
107 
(4S,6S)-2-(but-3-en-1-yloxy)-4,6-divinyl-1,3,2-dioxaphosphinane 2-oxide: 2.21b 
O
P
O
O
O
P
O
O
O
Cl
OH
n-BuLi, THF
-40 ºC to rt
2.21b  
 A solution of 3-buten-1-ol (0.049 mL, 0.564 mmol) in THF (2.82 mL) was cooled to -40 ºC.  
Dropwise addition of a 2.4 M n-butyllithium in hexanes (0.224 mL, 0.537 mmol) resulted in a 
yellow colored solution that was stirred for about 10 minutes. (4S,6S)-2-chloro-4,6-divinyl-1,3,2-
dioxaphosphinane 2-oxide (56 mg, 0.268 mmol) was delivered as a solution in THF (0.536 mL) 
dropwise, via cannulation.  The cold bath was dropped and the reaction was allowed to warm 
back to RT.  After 80 minutes, the SM was completely consumed (determined by TLC analysis) 
and quenched with NH4Cl (1 mL).  The mixture was partitioned with EtOAc (5 mL) and H2O (5 
mL).  Aqueous layer extracted three times with EtOAc (5 mL portions) and the collected 
organics were washed once with brine (5 mL), dried with Na2SO4 and filtered.  Filtrate was 
concentrated under reduced pressure and purified via flash chromatography in 2:1, 
hexanes:EtOAc, yielding 2.21b as a yellow oil (49 mg, 75% yield). 
[!]D +99.0 (c = 0.20, CH2Cl2); 
FTIR (neat) 3080.11, 2916.17, 2848.67, 2360.71, 1647.10, 1641.31, 1280.65, 1265.22, 1012.56, 
989.41, 736.76 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) " ppm 6.04 (ddd, J = 17.2, 10.6, 6.1 Hz, 1H), 5.91 (dddd, J = 17.3, 
10.7, 5.2, 1.7 Hz, 1H), 5.80 (ddt, J = 17.1, 10.3, 6.7 Hz, 1H), 5.49-5.36 (m, 2H), 5.28-5.33 (m, 
2H), 5.15 (ddd, J = 17.2, 3.2, 1.6 Hz, 1H), 5.10 (ddd, J = 10.3, 2.8, 1.2 Hz, 1H), 4.95-5.08 (m, 
2H), 4.10-4.20 (m, 2H), 2.46 (q, J = 6.6 Hz, 2H), 2.17 (dddd, J = 14.7, 8.2, 4.9, 1.5 Hz, 1H), 2.05 
(dddd, J = 14.7, 5.3, 3.6, 1.9 Hz, 1H);  
108 
13
C NMR (CDCl3, 125 MHz) " ppm 135.1 (d, JC-P = 4.2 Hz), 135.0, 133.5, 118.2, 117.6 (d, JC-P 
= 33.5 Hz), 77.8 (d, JC-P = 6.8 Hz), 76.1 (d, JC-P = 6.1 Hz), 66.9 (d, JC-P = 5.9 Hz), 35.2 (d, JC-P = 
7.7 Hz), 34.7 (d, JC-P = 6.6 Hz), 29.7; 
31
P NMR (162 MHz, CDCl3) " ppm -7.01; 
HRMS calculated for C11H17NaO4P (M+Na)
+
 267.0762; found 267.0732 (ESI). 
109 
(4R,6R)-2-(pent-4-en-1-yloxy)-4,6-divinyl-1,3,2-dioxaphosphinane 2-oxide: 2.21c 
n-BuLi, THF
-40 º to 0 ºC
O
P
O O
O
O
P
O O
Cl OH
2.21c  
 
 A solution of 4-penten-1-ol (0.037 mL, 0.357 mmol) in THF (1.79 mL) was cooled to  
-40 ºC.  Dropwise addition of n-butyllithium (0.142 mL, 0.340 mmol, 2.4 M in hexanes) resulted 
in a yellow colored solution, which was stirred at -40 ºC for about 10 minutes. (4R,6R)-2-chloro-
4,6-divinyl-1,3,2-dioxaphosphinane 2-oxide (0.071 mg, 0.357 mmol) in THF (0.680 mL) was 
added dropwise through cannulation.  After consumption of SM (2 hours by TLC analysis), the 
reaction was quenched with NH4Cl (1 mL) at 0 ºC and the mixture was allowed to warm to RT.  
Mixture was partitioned with EtOAc (5 mL) and H2O (5 mL) and the aqueous layer was 
extracted with EtOAc (3x5mL).  Collected organics were washed once with brine (5 mL), dried 
with anhydrous Na2SO4 and filtered.  Filtrate was concentrated under reduced pressure and 
purified via flash chromatography in 2:1, hexanes:EtOAc.  Phosphate 2.21c was obtained as a 
yellow oil (67 mg, 81% yield). 
[!]D -69.1 (c =  0.33, CH2Cl2); 
FTIR (neat) 3080.11, 2960.53, 2923.88, 2360.71, 2341.42, 2331.78, 1733.89, 1718.46, 1637.45, 
1429.15, 1280.65, 1118.64, 1010.63, 968.20, 925.77 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) " ppm 6.03 (ddd, J = 17.2, 10.6, 6.0 Hz, 1H), 5.92 (dddd, J = 17.3, 
10.6, 5.2, 1.6 Hz, 1H), 5.80 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H), 5.47 (ddd, J = 17.1, 1.5, 0.9 Hz, 
1H), 5.38 (ddd, J = 17.2, 1.4, 1.0 Hz, 1H), 5.29-5.33 (m, 2H), 4.95-5.08 (m, 4H), 4.09-4.14 (m, 
110 
2H), 2.13-2.18 (m, 2H), 2.05 (dddd, J = 14.7, 5.4, 3.6, 1.8 Hz, 1H), 1.76-1.83 (m, 2H), 1.61 (s, 
1H);  
13
C NMR (CDCl3, 125 MHz) " ppm 137.2, 135.1 (d, JC-P = 1.4 Hz), 135.0 (d, JC-P = 2.5 Hz), 
118.1, 117.5, 115.5, 77.6 (d, JC-P = 6.7 Hz), 76.1 (d, JC-P = 6.1 Hz), 67.3 (d, JC-P = 5.9 Hz), 35.2 
(d, JC-P = 7.6 Hz), 29.6, 29.4 (d, JC-P = 6.8 Hz); 
31
P NMR (162 MHz, CDCl3) " ppm -6.91; 
HRMS calculated for C12H19O4P (M+Na)
+ 281.0919; found 281.0886 (ESI). 
111 
(4S,6S)-2-((2-methylallyl)oxy)-4,6-divinyl-1,3,2-dioxaphosphinane 2-oxide: 2.21d 
O
P
O
O
O
CH3
Cl
P
O
O
O
H3C
OH
n-BuLi, THF
-40 ºC to rt
2.21d  
 Alcohol (0.032 mL, 0.385 mmol) was taken up in THF (1.93 mL) and cooled to -40 ºC.  
Dropwise addition of a 2.4 M n-butyllithium solution in hexanes (0.160 mL, 0.385 mmol) 
provided a yellow colored solution, which was stirred for 10 minutes.  Dropwise addition of a 
solution of (4S,6S)-2-chloro-4,6-divinyl-1,3,2-dioxaphosphinane 2-oxide (73 mg, 0.350 mmol) 
in THF (0.700 mL) via cannulation provided no color change.  The cold bath was dropped after 
addition and the reaction was stirred to RT for about 70 minutes.  Consumption of SM was 
determined by TLC analysis and the reaction was quenched with NH4Cl (1 mL) and partitioned 
with CH2Cl2 (5 mL) and H2O (5 mL).  The aqueous layer was extracted with CH2Cl2 (4 x 5 mL).  
Collected organics were washed once with brine (5 mL), dried with Na2SO4 and filtered.  Filtrate 
was concentrated under reduced pressure and purified via flash chromatography in 3:2, 
hexanes:EtOAc.  Collected fractions were concentrated under reduced pressure resulting in a 
yellow oil (69 mg, 81% yield).   
[!]D +59.6 (c = 0.55, CH2Cl2); 
FTIR (neat) 3083.96, 2920.03, 2538.78, 2339.49, 1649.02, 1452.30, 1431.08, 1411.80, 1282.57, 
1006.77, 925.77, 877.55 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) " ppm 6.04 (ddd, J = 17.2, 10.6, 5.9 Hz, 1H), 5.91 (dddd, J = 17.3, 
10.6, 5.2, 1.7 Hz, 1H), 5.36-5.49 (m, 2H), 5.28-5.34 (m, 2H), 4.94-5.09 (m, 4H), 4.50 (d, J = 7.2 
Hz, 2H), 2.18 (dddd, J = 14.7, 8.1, 4.9, 1.5 Hz, 1H), 2.06 (dddd, J = 14.8, 5.3, 3.7, 1.9 Hz, 1H), 
1.78 (s, 3H); 
112 
13
C NMR (CDCl3, 125 MHz) " ppm 140.0 (d, JC-P = 7.4 Hz), 135.0 (d, JC-P = 3.0 Hz), 134.9 (d, 
JC-P = 1.0 Hz), 118.2, 117.5, 113.4, 77.8 (d, JC-P = 6.8 Hz), 76.2 (d, JC-P = 6.1 Hz), 71.0 (d, JC-P = 
5.5 Hz), 35.1 (d, JC-P = 7.7 Hz), 19.04; 
31
P NMR (162 MHz, CDCl3) " ppm -7.02; 
HRMS calculated for C11H17O4P (M+Na)
+ 267.0762; found 267.0744 (ESI).
113 
(3R,4S)-3-methyl-4-(((4S,6S)-2-oxido-4,6-divinyl-1,3,2-dioxaphosphinan-2-yl)oxy)hex-5-en-
2-one: 2.21e 
O
P
O
O
O
Cl
P
O
O
O
NaHMDS, -78 ºC to rt
H3C
O
CH3
CH3
O
OCH3
OH
2.21e  
 Alcohol (93 mg, 0.644 mmol) was taken up in THF (3.22 mL) and cooled to -78 ºC.  A 
freshly prepared 1.0 M NaHMDS (0.644 mL, 0.644 mmol) in THF was added on dropwise and 
stirred for about 15 minutes. (4S,6S)-2-chloro-4,6-divinyl-1,3,2-dioxaphosphinane 2-oxide (112 
mg, 0.537 mmol) was delivered dropwise as a solution in THF (1.07 mL) via cannulation, in 
which the resulting yellow colored solution was allowed to warm to RT in the cold bath.  After 
stirring for about 16.5 hours, the reaction was quenched with NH4Cl (1 mL) and partitioned with 
H2O (5 mL) and EtOAc (5 mL).  The aqueous layer was extracted with EtOAc (3 x 5 mL).  
Collected organics were washed once with brine (5 mL), dried with Na2SO4 and filtered.  Filtrate 
was concentrated under reduced pressure and purified via flash chromatography in 2:1, 
hexanes:EtOAc.  After collecting the fractions of the major TLC spot, concentrating them under 
reduced pressure provided a yellow oil (73 mg, 43% yield).   
[!]D +59.6 (c =, CH2Cl2); 
FTIR (neat) 2950.89, 2925.81, 2362.64, 2343.35, 1733.89, 1301.86, 1205.43, 1124.42, 1087.78, 
997.13, 966.27, 877.55 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) " ppm 6.05 (ddd, J = 17.2, 10.6, 6.0 Hz, 1H), 5.84-5.94 (m, 2H), 
5.33-5.50 (m, 3H), 5.29 (dd, J = 10.6, 1.2 Hz, 3H), 5.22 (ddd, J =8.3, 6.2, 4.9, Hz, 1H), 4.95-5.08 
114 
(m, 2H), 3.68 (s, 3H), 2.73-2.82 (m, 1H), 2.12-2.19 (m, 1H), 2.04 (dddd, J = 14.8, 5.5, 3.8, 1.9 
Hz, 1H), 1.20 (d, J = 7.1 Hz, 3H); 
13
C NMR (CDCl3, 125 MHz) " ppm 173.3, 135.1 (d, JC-P = 5.7 Hz), 135.1, 134.1 (d, JC-P = 2.8 
Hz), 118.6, 118.0, 117.5, 80.3 (d, JC-P = 5.6 Hz), 78.0 (d, JC-P = 7.0 Hz), 76.1 (d, JC-P = 6.2 Hz), 
52.0, 44.5 (d, JC-P = 6.6 Hz), 35.1 (d, JC-P = 7.7 Hz), 11.2; 
31
P NMR (162 MHz, CDCl3) " ppm -7.96; 
HRMS calculated for C14H21O6P (M+Na)
+ 339.0973; found 339.0944 (ESI).  
115 
(4S,6S)-2-(((3S,5S)-5-hydroxyhepta-1,6-dien-3-yl)oxy)-4,6-divinyl-1,3,2-dioxaphosphinane 
2-oxide: 2.21f 
O
P
O
O
O
Cl
P
O
O
O
OH
OH OH
n-BuLi, -40 º to 0 ºC
THF
2.21f  
 (S,S)-diol 1.24 (37 mg, 0.292 mmol) was dissolved in THF (1.45 mL) and cooled to -40 ºC.  
Dropwise addition of n-butyllithium (0.123 mL, 0.292 mmol, 2.4 M in hexanes) gave a yellow 
colored solution, which was stirred at -40 ºC for about 10 minutes.  A solution of (4S,6S)-2-
chloro-4,6-divinyl-1,3,2-dioxaphosphinane 2-oxide (58 mg, 0.278 mmol) in THF (0.556 mL) 
was delivered dropwise via cannulation.  Reaction was quenched after 2.5 hours with saturated 
aq. NH4Cl (1 mL) and partitioned with EtOAc (5 mL) and H2O (5 mL).  Aqueous layer was 
extracted with EtOAc (3 x 5mL).  Collected organics were washed once with brine (5 mL), dried 
with anhydrous Na2SO4 and filtered.  Filtrated was concentrated and purified via flash 
chromatography in 2:1, hexanes:EtOAc providing phosphate (25 mg, 30% yield) as a yellow oil. 
[!]D +32.0 (c = 0.35, CH2Cl2); 
FTIR (neat) 3352.05, 3085.89, 2358.78, 2341.42, 1716.53, 1699.17, 1521.73, 1265.22, 1118.64, 
1056.92, 989.41, 927.70, 873.69 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) "  ppm 6.05 (ddd, J = 16.7, 10.7, 5.9 Hz, 1H), 5.82-5.96 (m, 3H), 
5.27-5.45 (m, 6H), 5.20 (ddd, J = 10.4, 1.0 Hz, 1H), 5.05-5.15 (m, 3H), 4.91-4.96 (m, 1H), 4.42 
(br s, 1H), 4.07-4.24 (br m, 1H), 2.20 (dddd, J = 14.9, 8.6, 5.0, 1.4, 1H), 2.05 (dddd, J = 14.8, 
5.2, 3.3, 1.9 Hz, 1H), 1.83 (ddd, J = 14.0, 11.0, 2.7 Hz, 1H), 1.64-1.73 (m, 1H); 
116 
13
C NMR (CDCl3, 125 MHz) " ppm 139.9, 136.6 (d, JC-P = 4.7 Hz), 134.8 (d, JC-P = 2.6 Hz), 
134.7 (s, JC-P = 8.2 Hz), 118.3, 117.7, 117.2, 114.2, 78.7 (d, JC-P = 6.8 Hz), 76.6 (d, JC-P = 5.2 
Hz), 75.9 (d, JC-P = 5.9 Hz), 67.0, 43.5 (d, JC-P = 3.9 Hz), 35.1 (d, JC-P = 7.5 Hz); 
31
P NMR (162 MHz, CDCl3) " ppm -5.32; 
HRMS calculated for C14H21O5P (M+Na)
+
 323.1024; found 323.1011 (ESI). 
117 
(4R,6R)-2-(((3R,5R)-5-((tert-butyldimethylsilyl)oxy)hepta-1,6-dien-3-yl)oxy)-4,6-divinyl-
1,3,2-dioxaphosphinane 2-oxide: 2.21g 
O
P
O O
OH OTBS
n-BuLi, -40 º to 0 ºC
THF
Cl
O
P
O O
O OTBS
2.21g  
 Alcohol S2 (119 mg, 0.501 mmol) was dissolved in THF (2.5 mL) and cooled to -40 ºC.  
Dropwise addition of n-butyllithium (0.190 mL, 0.455 mmol, 2.4 M solution in hexanes) gave a 
yellow colored solution, which was stirred at -40 ºC for about 10 minutes.  A solution of 
(4R,6R)-2-chloro-4,6-divinyl-1,3,2-dioxaphosphinane 2-oxide (95 mg, 0.455 mmol) dissolved in 
THF (0.910 mL) was added dropwise via cannlae.  The resultant solution was allowed to warm 
slowly to 0 ºC.  After 3 hours, saturated aq. NH4Cl (1 mL) was added slowly at 0 ºC and the 
mixture was allowed to warm to RT.  The mixture was partitioned with EtOAc (5 mL) and H2O 
(5 mL) and the aqueous layer was extracted with EtOAc (3x5 mL).  Collected organics were 
washed once with brine (5 mL), dried with Na2SO4 and filtered.  Filtrate was concentrated under 
reduced pressure and purified via flash chromatography in 4:1, hexanes:EtOAc.  The collected 
product was a yellow oil (77 mg, 41% yield). 
[!]D -49.2 (c = 0.12, CH2Cl2); 
FTIR (neat) 2954.74, 2927.74, 2358.78, 2341.42, 1716.53, 1558.38, 1521.73, 1506.30, 1284.50, 
1259.43, 1083.92, 991.34, 835.12, 777.26 cm
-1
; 
1
H NMR (CDCl3, 500 MHz)
5
 " ppm 6.02 (ddd, J = 17.2, 10.6, 5.2 Hz, 1H), 5.85-5.95 (m, 2H), 
5.80 (ddd, J = 17.2, 10.3, 6.9 Hz, 1H), 5.31-5.46 (m, 3H), 5.29 (dd, J = 10.6, 5.3 Hz, 2H), 5.22 
                                                
5
 Peak at " 1.57 is presumed to be a H2O peak, which was difficult to remove. 
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(dt, J = 10.4, 0.9 Hz, 1H), 5.15 (dt, J = 17.2, 1.3 Hz, 1H), 5.01-5.08 (m, 2H), 4.91-4.98 (m, 2H), 
4.22-4.27 (m, 1H), 2.15 (dddd, J = 14.5, 7.7, 4.7, 1.4 Hz, 1H), 2.04 (dddd, J = 14.6, 5.6, 3.8, 1.8 
Hz, 1H), 1.93 (ddd, J = 14.0, 8.1, 4.8 Hz, 1H), 1.75-1.82 (m, 1H), 0.89 (s, 9H), 0.11 (s, 3H), 0.04 
(s, 3H); 
13
C NMR (CDCl3, 125 MHz) " ppm 141.3, 136.9 (d, JC-P = 2.3 Hz), 135.3 (d, JC-P = 3.8 Hz), 
135.2, 135.1, 117.8, 117.7, 117.4, 114.6, 77.8 (d, JC-P = 6.0 Hz), 77.4, 75.9, 75.8, 70.5, 44.7 (d, 
JC-P = 7.3 Hz), 35.3 (d, JC-P = 7.5 Hz), 25.9 (3), 18.1; 
31
P NMR (162 MHz, CDCl3) " ppm -7.90; 
HRMS calculated for C20H35O5PSi (M+Na)
+ 437.1889; found 437.1860 (ESI). 
119 
(4R,6R)-4,6-diallyl-2-(allyloxy)-1,3,2-dioxaphosphinane 2-oxide: 2.22 
OH
O
P
O
O
O
P
O
O
O
Cl
n-BuLi, THF
-40 ºC to rt
S1 2.22  
 Allyl alcohol (0.013 mL, 0.195 mmol) was dissolved in THF (0.975 mL) and cooled to -40 
ºC.  Dropwise addition of n-butyllithium (0.074 mL, 0.177 mmol, 2.4 M solution in hexanes) 
provided a yellow colored solution, which was stirred for about 10 minutes.  Phosphoryl chloride 
S1 (0.042 mg, 0.177 mmol) was added as a solution in THF (0.354 mL) dropwise via 
cannulation.  Reaction was allowed back to RT and stirred for about 90 minutes (S1 consumed 
by TLC analysis), at which saturated aqueous NH4Cl (1 mL) was added.  Mixture was 
partitioned with H2O (5 mL) and EtOAc (5 mL) and the aqueous layer was extracted with EtOAc 
(3x5 mL).  Collected organics were washed once with brine (5 mL), dried with anhydrous 
Na2SO4 and filtered.  Filtrate was concentrated under reduced pressure and purified via flash 
chromatography in 2:1, hexanes:EtOAc.  Phosphate 2.22 was isolated as a yellow oil (29 mg, 
63% yield). 
[!]D +29.1 (c = 0.33, CH2Cl2); 
FTIR (neat) 3076.25, 2927.74, 2538.78, 2341.42, 1645.17, 1286.43, 1095.49, 1016.42, 975.91, 
919.98 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) " ppm 5.96 (ddd, J = 22.6, 10.9, 5.6 Hz, 1H), 5.72-5.84 (m, 2H), 
5.37 (ddd, J = 17.1, 3.0, 1.5 Hz, 1H), 5.26 (ddd, J = 10.4, 2.4, 1.2 Hz, 1H), 5.12-5.18 (m, 4H), 
4.49-4.67 (m, 4H), 2.63-2.70 (m, 1H), 2.56 (dtd, J = 14.3, 6.6, 1.2 Hz, 1H), 2.35-2.44 (m, 2H), 
1.99-2.07 (m, 1H), 1.88 (dddd, J = 14.7, 5.3, 3.6, 1.9 Hz, 1H);  
120 
13
C NMR (CDCl3, 125 MHz) " ppm 132.6 (d, JC-P = 7.0 Hz), 132.5, 132.2, 119.0, 118.8, 118.3, 
77.3 (d, JC-P = 7.1 Hz), 75.5 (d, JC-P = 6.7 Hz), 68.1 (d, JC-P = 5.3 Hz), 39.9 (d, JC-P = 7.6 Hz), 38.8 
(d, JC-P = 3.0 Hz), 33.0 (d, JC-P = 6.9 Hz); 
31
P NMR (162 MHz, CDCl3) " ppm -6.21; 
HRMS calculated for C12H19O4P (M+H)
+
 259.1099; found 259.1069 (ESI). 
121 
(4R,6R)-4,6-diallyl-2-vinyl-1,3,2-dioxaphosphinane 2-oxide: 2.23 
OH OH POCl2
DMAP, Et3N
P
O
O
O
(R,R)-2.9
2.23  
 (R,R)-diol 2.9 (34 mg, 0.218 mmol) was taken up in CH2Cl2 (1.09 mL) at RT.  DMAP (2.67 
mg, 0.0218 mmol) and Et3N (0.136 mL, 0.979 mmol) were added and the solution was cooled to 
0 ºC.  Freshly prepared vinylphosphonyl dichloride
6
 (0.034 mL, 0.326 mmol) was added 
dropwise, resulting in a white suspension.  After 20 min, 2.9 was consumed (verified by TLC 
analysis) and the suspension was diluted with Et2O (5 mL) to crash out amine salts.  Salts were 
filtered from the liquid through a fritted funnel and rinsed thoroughly with Et2O (20 mL).  The 
filtrate was concentrated under reduced pressure and purified through a plug of SiO2 in 1:2, 
hexanes:EtOAc.  Collected fractions were concentrated under reduced pressure to give a yellow 
colored oil (44 mg, 88% yield). 
[!]D +60.5 (c = 0.40, CH2Cl2); 
FTIR (neat) 3083.96, 2880.24, 2358.78, 2341.42, 2331.78, 1701.10, 1670.24, 1280.65, 1118.64, 
1006.77, 991.34, 931.55 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) " ppm 6.24-6.35 (m, 1H), 6.05-6.18 (m, 2H), 5.72-5.82 (m, 2H), 
5.12-5.20 (m, 3H), 4.71 (tdd, J = 11.7, 6.5, 5.0 Hz, 1H), 4.33-4.42 (m, 1H), 2.63-2.70 (m, 1H), 
2.33-2.55 (m, 3H), 2.04 (dddd, J = 14.5, 6.2, 4.5, 1.5 Hz, 1H), 1.89-1.96 (m, 1H); 
                                                
6
 Synthesis of vinylphosphonyl dichloride: Herpel, R. H.; Vedantham, P.; Flynn, D. L.; Hanson, 
P. R. Tetrahedron Lett. 2006, 47, 6429-6432. 
122 
13
C NMR (CDCl3, 125 MHz) " ppm 135.6 (d, JC-P = 1.8 Hz), 132.5, 132.1, 126.8, 125.3, 118.9 
(d, JC-P = 9.9 Hz), 75.2 (d, JC-P = 6.7 Hz), 73.2 (d, JC-P = 6.5 Hz), 40.1 (d, JC-P = 3.9 Hz), 40.0 (d, 
JC-P = 2.1 Hz), 33.9 (d, JC-P = 6.7 Hz); 
31
P NMR (162 MHz, CDCl3) " ppm 12.57; 
HRMS calculated for C11H17O3P (M+Na)
+
 251.0813; found 251.0837 (ESI). 
123 
(4S,6S)-2-allyl-4,6-divinyl-1,3,2-dioxaphosphinane 2-oxide: 2.24 
P
O
O
OOH OH
POCl2
Et3N, DMAP
(S,S)-1.24
2.24  
 (S,S)-diol 1.24 (82 mg, 0.640 mmol) was taken up in toluene (5.0 mL) at RT.  After addition 
of Et3N (0.223 mL, 1.60 mmol) and DMAP (8 mg, 0.0640 mmol), the reaction flask was cooled 
to -40 ºC.  A solution of allylphosphonic dichloride
7
 (0.115 mL, 0.960 mmol) in toluene (1 mL) 
was added dropwise over 30 minutes.  The reaction was allowed to warm slowly in the cold bath 
to RT.  After the SM was consumed (determined by TLC analysis), the solution was 
concentrated under reduced pressure and the resulting residue was purified on flash 
chromatography (1:2, hexanes:EtOAc).  Collected fractions from the column were concentrated 
under reduced pressure to give a clear oil (127 mg, 93% yield). 
[!]D +82.9 (c = 0.35, CH2Cl2); 
FTIR (neat) 3083.96, 2923.88, 2358.78, 2331.78, 1652.88, 1637.45, 1419.51, 1263.29, 1118.64, 
1026.06, 925.77 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) " ppm 6.00 (ddd, J = 17.0, 10.7, 5.3 Hz, 1H), 5.75-5.90 (m, 2H), 
5.53 (ddd, 17.1, 1.5, 0.9 Hz, 1H), 5.20-5.40 (m, 5H), 5.04-5.10 (m, 1H), 4.85-4.95 (m, 1H), 2.73 
(ddt, J = 22.3, 7.4, 1.2 Hz, 2H), 2.03-2.17 (m, 2H); 
13
C NMR (CDCl3, 125 MHz) " ppm 135.6 (d, JC-P = 7.0 Hz), 135.4 (d, JC-P = 3.0 Hz), 127.3 (d, 
JC-P = 12.1 Hz), 120.2 (d, JC-P = 15.0 Hz), 117.9, 117.1, 76.5 (d, JC-P = 7.6 Hz), 73.1 (d, JC-P = 6.7 
Hz), 35.6 (d, JC-P = 7.7 Hz), 32.8 (d, JC-P = 140.2 Hz); 
31
P NMR (162 MHz, CDCl3) " ppm 21.69; 
                                                
7
 Allylphosphonic dichloride was purchased from Acros Organics. 
124 
HRMS calculated for C10H15O3P (M+Na)
+
 237.0657; found 237.0648 (ESI).
125 
(1S,6S,8S)-8-vinyl-9,10-dioxa-2-aza-1-phosphabicyclo[4.3.1]dec-4-ene 1-oxide: 2.26a 
NH
P
O
O
O cat-B (2 mol %)
CH2Cl2, 40 ºC
NH
P
O
O
O
2.21a 2.26a  
 Phosphoramidate 2.21a (20 mg, 0.0873 mmol) was taken up in dry and degassed (with Ar 
for 15 minutes) CH2Cl2 (6.0 mL) and heated to 40 ºC.  Cat-B (1.5 mg, 0.0017 mmol) was added 
and the solution turned a brown color.  After refluxing for 6 hours, SM material was completely 
consumed (by TLC analysis).  The reaction was allowed to cool to RT and the solution was 
concentrated under reduced pressure.  The resulting residue was purified via flash 
chromatography in EtOAc.  After collecting fractions and concentrating them under reduced 
pressure a white solid was obtained (17 mg, 94% yield). 
[!]D +61.5 (c = 0.33, CH2Cl2); 
FTIR (neat) 3257.55, 3240.19, 2956.67, 2923.88, 2852.52, 2358.78, 2331.78, 1677.95, 1612.38, 
1247.86, 1122.49, 1087.78, 1035.70, 1000.99, 966.27, 943.13, 921.91, 873.69 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) " ppm 6.00-6.05 (m, 1H), 5.88 (dddd, J = 17.3, 10.6, 5.3, 1.8 Hz, 
1H), 5.47 (ddd, J = 11.9, 3.7, 2.7 Hz, 1H), 5.41 (dt, J = 17.2, 1.3 Hz, 1H), 5.23 (dt, J = 10.6, 1.2 
Hz, 1H), 5.16 (d, J = 21.1 Hz, 1H), 5.03-5.07 (m, 1H), 4.01-4.08 (m, 1H), 3.33-3.46 (m, 1H), 
3.09 (s, 1H), 2.21 (ddd, J = 14.5, 11.9, 6.0 Hz, 1H), 1.73 (ddd, J = 14.5, 3.5, 2.1 Hz, 1H); 
13
C NMR (CDCl3, 125 MHz)
8
 " ppm 135.5 (d, JC-P = 10.1 Hz) 130.2, 128.1, 116.8, 76.8 (d, JC-P 
= 6.6 Hz) 74.9 (d, JC-P = 6.1 Hz) 38.9, 35.4 (d, JC-P = 6.0 Hz); 
31
P NMR (162 MHz, CDCl3) " ppm -5.63; 
HRMS calculated for C8H12NO3P (M+Na)
+
 224.0452; found 224.0421 (ESI). 
                                                
8
 Broad singlet at " 1.65 is presumed to result from water. 
126 
(1S,7S,9S,Z)-9-vinyl-2,10,11-trioxa-1-phosphabicyclo[5.3.1]undec-5-ene 1-oxide: 2.26b 
P
O
O
O
O
O
P
O
O
O cat-B (5 mol%)
DCE, 90 ºC
2.21b 2.26b  
 Phosphate 2.21b (19 mg, 0.0778 mmol) was dissolved in dry (passed through basic Al2O3) 
and degassed (with Ar for 15 minutes) 1,2-dichloroethane (5.2 mL) and heated to 90 ºC.  Cat-B 
(3.3 mg, 0.00389 mmol) was added resulting in an immediate color change from red to brown.  
After stirring for about 90 minutes, the reaction was cooled to RT.  The solution was 
concentrated under reduced pressure and the resulting residue was purified via flash 
chromatography in 1:2, hexanes:EtOAc.  Collected fractions were concentrated under reduced 
pressure providing a white solid (12 mg, 71% yield). 
[!]D +94.0 (c = 0.45, CH2Cl2); 
FTIR (neat) 3477.42, 2927.74, 2358.78, 2341.42, 2331.78, 1647.10, 1618.17, 1286.43, 1022.20, 
1000.99, 966.27 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) " ppm 5.78-5.88 (m, 2H), 5.53 (d, J = 11.7 Hz, 1H), 5.41 (d, J = 
17.5 Hz, 1H), 5.31 (br s, 1H), 5.22-5.28 (m, 1H), 5.06 (dd, J = 11.9, 5.3 Hz, 1H), 4.46 (ddd, J = 
10.7, 6.7, 1.7 Hz, 1H), 3.78 (dddd, J = 29.2, 15.1, 11.1, 4.1 Hz, 1H), 3.29-3.39 (m, 1H), 2.19 
(ddd, J = 14.6, 12.1, 6.0 Hz, 1H), 2.13 (ddd, J = 13.4, 8.7, 4.0 Hz, 1H), 1.81 (dd, J = 14.6, 1.6 
Hz, 1H);  
13
C NMR (CDCl3, 125 MHz) " ppm 135.0 (d, JC-P = 10.0 Hz ppm), 131.2, 126.4, 117.3 (d, JC-P = 
1.2 Hz), 78.2 (d, JC-P = 7.2 Hz), 77.1 (d, JC-P = 6.1 Hz), 63.0 (d, JC-P = 5.2 Hz), 36.2 (d, JC-P = 6.6 
Hz), 26.8;  
31
P NMR (162 MHz, CDCl3) " ppm -7.43; 
127 
HRMS calculated for C9H13O4P (M+Na)
+
 239.0449; found 239.0437 (ESI).
128 
(1S,6S,8S)-4-methyl-8-vinyl-2,9,10-trioxa-1-phosphabicyclo[4.3.1]dec-4-ene 1-oxide: 2.26c 
O
P
O
O
O
H3C
O
P
O
O
O
CH3
cat-B (5 mol %)
90 ºC, DCE
2.21d 2.26c  
 Phosphate 2.21d (23 mg, 0.0942 mmol) was dissolved in dry 1,2-dichloroethane (6.3 mL), 
which was degassed by bubbling with argon for ~15 min.  After heating the solution to 90 ºC, 
cat-B (4.0 mg, 0.00471 mmol) was added and kept at reflux for 10 hours.  Upon completion, the 
mixture was cooled to RT and concentrated under reduced pressure.  Residue was purified via 
flash chromatography in 1:2, hexanes:EtOAc providing a brown oil (16 mg, 80% yield). 
[!]D +19.5 (c = 0.60, CH2Cl2); 
FTIR (neat) 2923.88, 2358.78, 2341.42, 1699.17, 1558.38, 1299.93, 1134.07, 1114.78, 1056.92, 
1020.27, 999.06, 966.27, 904.55, 873.69, 831.26, 802.33 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) " ppm 5.86 (dddd, J = 17.2, 10.6, 5.4, 2.0 Hz, 1H), 5.42 (dt, J = 
17.2, 1.2 Hz, 1H), 5.30-5.32 (m, 1H), 5.26 (dt, J = 10.6, 1.1 Hz, 1H), 5.14 (br d, J = 24.6 Hz, 
1H), 5.00-5.06 (m, 2H), 4.17 (dd, J = 27.3, 14.5 Hz, 1H), 2.20 (ddd, J = 14.5, 12.1, 6.0 Hz, 1H), 
1.85 (d, J = 0.6 Hz, 3H), 1.77 (ddd, J = 14.6, 3.6, 2.3 Hz, 1H); 
13
C NMR (CDCl3, 125 MHz) " ppm 136.5, 134.8 (d, JC-P = 10.4 Hz), 123.1, 117.4, 76.4, (d, JC-P 
=  6.1 Hz), 66.9 (d JC-P = 6.3 Hz), 35.4 (d, JC-P = 6.0 Hz), 29.7, 23.1; 
31
P NMR (162 MHz, CDCl3) " ppm -3.61; 
HRMS calculated for C9H13O4P (M+Na)
+ 239.0449; found 239.0425 (ESI). 
129 
(R)-3-((1S,3S,6S,8S)-1-oxido-8-vinyl-2,9,10-trioxa-1-phosphabicyclo[4.3.1]dec-4-en-3-
yl)butan-2-one: 2.26d 
O
P
O
O
O
H3C
O
OCH3
cat-B (10 mol %)
PhH, 80 ºC O
P
O
O
O
H3C
O
OCH3
2.21e 2.26d  
 Phosphate 2.21e (26 mg, 0.0822 mmol) was taken up in dry (passed through plug of basic 
Al2O3) and degassed (with Ar for 15 minutes) benzene (8.22 mL) and heated to 80 ºC.  Cat-B 
(3.5 mg, 0.00411 mmol) was added and the solution immediately turned to a brown color.  After 
about 2 hours, a second portion of cat-B (3.5 mg) was added to the refluxing solution.  TLC 
analysis showed after 4.5 hours complete consumption of SM and the reaction was allowed to 
cool to RT.  The solution was concentrated under reduced pressure and the resulting residue was 
purified via flash chromatography in 1:2, hexanes:EtOAc.  After concentrating the collected 
fractions under reduced pressure, a white solid was obtained (19 mg, 79% yield). 
[!]D +37.5 (c = 0.16, CH2Cl2); 
FTIR (neat) 2921.96, 2358.78, 2341.42, 1733.89, 1699.17, 1301.86, 1124.42, 1087.78, 966.27 
cm
-1
; 
1
H NMR (CDCl3, 500 MHz) " ppm 5.92 (ddd, J = 11.9, 3.0, 2.1 Hz, 1H), 5.85 (dddd, J = 13.9, 
10.7, 5.3, 3.2 Hz, 1H), 5.58 (ddd, J = 11.9, 3.9, 2.4 Hz, 1H), 5.36-5.45 (m, 2H), 5.25-5.28 (m, 
1H), 5.15-5.24 (m, 1H), 4.96-5.02 (m, 1H), 3.74 (s, 3H), 2.76-2.83 (p, J = 7.0 Hz, 1H), 2.21 
(ddd, J = 14.7, 12.1, 6.2 Hz, 1H), 1.79 (ddd, J = 14.7, 3.6, 2.3 Hz, 1H), 1.32 (d, J = 7.1 Hz, 3H); 
130 
13
C NMR (CDCl3, 125 MHz) " ppm 173.0, 134.6 (d, JC-P = 10.4 Hz), 130.7, 129.6, 117.4 (d, JC-P 
= 1.1 Hz), 76.9, 76.3 (d, JC-P = 6.2 Hz), 74.2 (d, JC-P = 5.7 Hz), 52.2, 44.5 (d, JC-P = 10.4 Hz), 
34.9 (d, JC-P = 6.0 Hz), 12.6; 
31
P NMR (162 MHz, CDCl3) " ppm -5.21; 
HRMS calculated for C12H17O6P (M+Na)
+
 311.0660; found 311.0637 (ESI).  
131 
(1S,3S,5S)-3-vinyl-2,9-dioxa-1-phosphabicyclo[3.3.1]non-6-ene 1-oxide: 2.26e 
P
O
O
OP
O
O
O
cat-B (3 mol %)
PhH, 80 ºC
2.24 2.26e  
 Phosphonate 2.24 (25 mg, 0.117 mmol) was taken up in dry benzene (12 mL), which was 
not degassed.  After addition of cat-B (3.0 mg, 0.0035 mmol), the reaction was brought to reflux.  
After 3 hours, the reaction was cooled to RT (SM consumed by TLC) and the solution was 
concentrated under reduced pressure.  Flash chromatography (EtOAc) provided a colorless oil 
(19.1 mg, 88% yield). 
[!]D +58.7 (c = 0.55, CH2Cl2); 
FTIR (neat) 3442.70, 2956.67, 2925.81, 1649.02, 1598.88, 1298.00, 1249.79, 1074.28, 1016.42, 
941.20, 981.41, 784.97 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) " ppm 6.08-5.97 (dddd, J = 34.0, 10.2, 5.0, 3.2 Hz, 1H), 5.83-5.88 
(m, 2H), 5.39 (dt, J = 17.1, 1.2 Hz, 1H), 5.27-5.33 (m, 1H), 5.21 (d, J = 10.6 Hz, 1H), 4.98-5.05 
(m, 1H), 2.70-2.83 (m, 1H), 2.45-2.57 (m, 1H), 2.25 (ddd, J = 14.6, 11.8, 4.4 Hz, 1H), 1.74 (ddd, 
J = 14.5, 5.1, 2.1 Hz, 1H); 
13
C NMR (CDCl3, 125 MHz) " ppm 135.4 (d, JC-P = 7.7 Hz), 127.2 (d, JC-P = 13.7 Hz), 125.7 (d, 
JC-P = 8.9 Hz), 117.0, 78.2 (d, JC-P = 6.2 Hz), 76.7 (d, JC-P = 6.4 Hz), 34.3 (d, JC-P = 6.5 Hz), 24.5 
(d, JC-P = 124.9 Hz); 
31
P NMR (162 MHz, CDCl3) " ppm 15.84; 
HRMS calculated for C8H11O3P (M+Na)
+ 209.0344; found 209.0323 (ESI). 
132 
(1R,3R,5R)-3-allyl-2,9-dioxa-1-phosphabicyclo[3.3.1]non-7-ene 1-oxide: 2.26f 
P
O
O
OP
O
O
O
cat-B (2 mol %)
CH2Cl2, 40 ºC
2.23 2.26f  
 Phosphonate 2.23 (19 mg, 0.0833 mmol) was taken up in CH2Cl2 (8.3 mL) that had been 
degassed for 15 min by bubbling through with Ar.  After heating the solution to 40 ºC, cat-B (1.4 
mg, 0.00167 mmol) was added.  The reaction was complete in less than 15 minutes (determined 
by TLC analysis) and was quenched with 2-3 drops of H2O.  The mixture was cooled to RT and 
then concentrated.  Purification via flash chromatography (1:2, hexanes:EtOAc) yielded a white 
solid (12 mg, 71% yield).  
[!]D -25.0 (c = 0.20, CH2Cl2); 
FTIR (neat) 2918.10, 2358.78, 2341.42, 1608.52, 1276.79, 1091.63, 1039.56, 945.05, 802.33 
cm
-1
; 
1
H NMR (CDCl3, 500 MHz) " ppm 6.85 (ddddd, J = 44.5, 12.8, 4.3, 2.8, 1.2 Hz, 1H), 5.95 
(dddd, J = 18.6, 12.8, 2.7, 1.9, 1H), 5.75-5.84 (m, 1H), 5.13-5.16 (m, 1H), 5.12 (t, J = 1.1 Hz, 
1H), 5.01 (ddd, J = 16.9, 6.9, 5.7 Hz, 1H), 4.44 (dtd, J = 8.4, 6.1, 2.3 Hz, 1H), 2.96-3.05 (m, 1H), 
2.46-2.53 (m, 1H), 2.33-2.41 (m, 1H), 2.18-2.29 (m, 2H), 1.67 (ddd, J = 14.6, 4.3, 2.2 Hz, 1H) 
ppm; 
13
C NMR (CDCl3, 125 MHz) " ppm 147.7 (d, JC-P = 0.9 Hz), 132.2, 118.9, 117.1 (d, JC-P = 161.4 
Hz), 76.4 (d, JC-P = 6.0 Hz), 76.0 (d, JC-P = 5.6 Hz), 40.5 (d, JC-P = 8.5 Hz), 36.7 (d, JC-P = 7.2 
Hz), 31.7 (d, JC-P = 13.2 Hz); 
31
P NMR (162 MHz, CDCl3) " ppm -6.13; 
HRMS calculated for C9H13O3P (M+Na)
+
 223.0500; found 223.0482 (ESI).
133 
(4R,6R)-nona-1,8-diene-4,6-diol: 2.9 
 
 
 
134 
(4R,6R)-4,6-diallyl-2-chloro-1,3,2-dioxaphosphinane 2-oxide: S1 
 
 
 
 
 
135 
 
136 
 
(3R,5R)-5-((tert-butyldimethylsilyl)oxy)hepta-1,6-dien-3-ol: S2 
 
 
 
137 
 
(4S,6S)-2-(allylamino)-4,6-divinyl-1,3,2-dioxaphosphinane 2-oxide: 2.21a 
 
 
138 
 
139 
(4S,6S)-2-(but-3-en-1-yloxy)-4,6-divinyl-1,3,2-dioxaphosphinane 2-oxide: 2.21b 
 
 
140 
 
141 
(4R,6R)-2-(pent-4-en-1-yloxy)-4,6-divinyl-1,3,2-dioxaphosphinane 2-oxide: 2.21c 
 
 
 
142 
 
143 
(4S,6S)-2-((2-methylallyl)oxy)-4,6-divinyl-1,3,2-dioxaphosphinane 2-oxide: 2.21d 
 
 
 
144 
 
145 
(3R,4S)-3-methyl-4-(((4S,6S)-2-oxido-4,6-divinyl-1,3,2-dioxaphosphinan-2-yl)oxy)hex-5-en-
2-one: 2.21e 
 
 
146 
 
147 
(4S,6S)-2-(((3S,5S)-5-hydroxyhepta-1,6-dien-3-yl)oxy)-4,6-divinyl-1,3,2-dioxaphosphinne 2-
oxide: 2.21f 
 
 
148 
 
149 
(4R,6R)-2-(((3R,5R)-5-((tert-butyldimethylsilyl)oxy)hepta-1,6-dien-3-yl)oxy)-4,6-divinyl-
1,3,2-dioxaphosphinane 2-oxide: 2.21g 
 
 
150 
 
151 
(4R,6R)-4,6-diallyl-2-(allyloxy)-1,3,2-dioxaphosphinane 2-oxide: 2.22 
 
 
152 
 
153 
(4R,6R)-4,6-diallyl-2-vinyl-1,3,2-dioxaphosphinane 2-oxide: 2.23 
 
 
154 
 
155 
(4S,6S)-2-allyl-4,6-divinyl-1,3,2-dioxaphosphinane 2-oxide: 2.24 
 
 
156 
 
157 
(1S,6S,8S)-8-vinyl-9,10-dioxa-2-aza-1-phosphabicyclo[4.3.1]dec-4-ene 1-oxide:  2.26a 
 
 
158 
 
159 
(1S,7S,9S,Z)-9-vinyl-2,10,11-trioxa-1-phosphabicyclo[5.3.1]undec-5-ene 1-oxide: 2.26b 
 
 
160 
 
161 
(1S,6S,8S)-4-methyl-8-vinyl-2,9,10-trioxa-1-phosphabicyclo[4.3.1]dec-4-ene 1-oxide: 2.26c 
 
 
162 
 
163 
(R)-3-((1S,3S,6S,8S)-1-oxido-8-vinyl-2,9,10-trioxa-1-phosphabicyclo[4.3.1]dec-4-en-3-
yl)butan-2-one: 2.26d 
 
 
 
164 
 
165 
(1S,3S,5S)-3-vinyl-2,9-dioxa-1-phosphabicyclo[3.3.1]non-6-ene 1-oxide: 2.26e 
 
 
166 
 
167 
(1R,3R,5R)-3-allyl-2,9-dioxa-1-phosphabicyclo[3.3.1]non-7-ene 1-oxide: 2.26f 
 
 
168 
 
169 
(4S,6R)-4-((R)-but-3-en-2-yl)-6-(5-(4-methoxybenzyloxy)pentyl)-2,2-dimethyl-1,3-dioxane: 
S3
9
 
PMBO
O O
Me
MeMe
PMBO
OH OH
Me
2,2-DMP, PPTS
CH2Cl2
3.11 S3  
Diol 3.11 (2.00 g, 5.95 mmol) was taken up in CH2Cl2 (8 mL) at RT.  2,2-
Dimethoxypropane (8 mL) and PPTS (150 mg, 0.595 mmol) were added respectively and the 
clear solution was stirred until completion.  The reaction was quenched with sat. aq. NaHCO3 
(15 mL) and diluted with CH2Cl2.  The aqueous layer was extracted with CH2Cl2 (3 x 25 mL) 
and the combined organic layers were washed once with brine (30 mL), dried (Na2SO4) and 
concentrated under reduced pressure.  Compound S3 was isolated using flash chromatography 
(19:1, hexanes:EtOAc) as a clear oil in 98% yield (2.18 g).  
[!]D -36.3 (c = 0.40, CH2Cl2);  
FTIR (neat) 2983, 2935, 2856, 1612, 1512, 819 cm
 -1
;  
1
H NMR (CDCl3, 500 MHz) " ppm 7.25 (d, J = 8.4 Hz, 2H), 6.87 (d, J = 8.6 Hz, 2H), 5.83 (ddd, 
J =17.4, 10.5, 7.3 Hz, 1H), 5.03 (ddd, J = 17.5, 11.0, 2.6 Hz, 2H), 4.43 (s, 2H), 3.80 (s, 3H), 
3.66-3.74 (m, 1H), 3.63 (ddd, J =9.7, 6.3 Hz, 1H), 3.45 (t, J =6.6 Hz, 2H), 2.18-2.26 (m, 1H), 
1.64-1.71 (m, 1H), 1.53-1.63 (m, 2H), 1.35-1.55 (m, 6H), 1.32 (s, 6H), 1.24-1.30 (m, 1H), 0.98 
(d, J = 6.9 Hz, 3H);  
13
C NMR (CDCl3, 125 MHz) " ppm 159.1, 140.9, 130.7, 129.3, 114.4, 113.7, 100.3, 72.5, 70.1, 
70.0, 66.8, 55.3, 42.1, 36.3, 35.9, 29.7, 26.2, 25.3, 24.7, 24.4, 15.3;   
HRMS calculated for C23H36NaO4 (M+Na)
+
 319.0198; found 319.0187 (ESI). 
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 Spectra for compounds on pages 70-94 have been shown in Joshua D. Waetzig's dissertation 
(2008). 
170 
(R)-2-((4S,6R)-6-(5-(4-methoxybenzyloxy)pentyl)-2,2-dimethyl-1,3-dioxan-4-yl)propan-1-ol: 
3.12 
1. OsO4, NMO
then NaIO4
2. NaBH4, EtOH
PMBO
O O
Me
MeMe
PMBO
O O
Me
OH
MeMe
S3 3.12  
 Olefin S3 (1.50 g, 3.99 mmol) was taken up in a 9:1 mixture of acetone:water (20 mL) at 
room temperature.  N-methyl morpholine oxide (933 mg, 7.98 mmol) and OsO4 (0.19 mL, 0.08 
mmol, 4% aq.) were added and the reaction was stirred for approximately 12 h until olefin was 
completely consumed.  The mixture was then diluted with phosphate buffer pH 7 (2x’s the 
volume of t-BuOH) and NaIO4 was added (3.41 mg, 16.0 mmol).  The reaction was stirred 
vigorously for approximately 2 h when until the diol was completely consumed.  The reaction 
was quenched with solid Na2SO3 (2.0 g).  Acetone was removed under reduced pressure.  The 
residue was partitioned with EtOAc (20 mL) and H2O (10 mL) and the aqueous layer was 
extracted with EtOAc (3 x 20 mL).  The collected organics were washed once with brine (20 mL 
portion) and dried with Na2SO4.  After concentrating under reduced pressure, the product was 
purified using flash chromatography (5:1, hexanes:EtOAc) to generate the corresponding 
aldehyde (yield assumed quantitative) as a yellow oil. 
 The resultant aldehyde was taken up in EtOH (16 mL) and cooled to 0 °C. NaBH4 (303 
mg, 7.98 mmol) was added and the reaction was slowly brought back to RT. Upon completion 
(~45 min), the solution was partitioned with 2:1, Et2O:H2O (40 mL). The aqueous layer was 
extracted with Et2O (3x5 mL) and the organic layers were combined, washed with brine (30 
mL), dried (MgSO4) and concentrated under reduced pressure.  Purification with flash 
chromatography (1:2, hexanes:EtOAc) afforded 3.12 (1.35 g) as a clear oil in 88% yield over two 
steps. 
171 
[!]D -0.26 (c = 0.18, CH2Cl2);  
FTIR (neat) 3442, 2933, 2856, 1612, 1512, 819 cm
 -1
;  
1
H NMR (CDCl3, 500 MHz) " ppm 7.25 (d, J = 8.5 Hz, 2H), 6.87 (d, J = 8.6 Hz, 2H), 4.43 (s, 
2H), 3.81 (s, 3H), 3.73-3.79 (m, 1H), 3.68 (ddd, J = 9.2, 6.3 Hz, 1H), 3.58 (d, J = 5.1 Hz, 2H), 
3.43 (t, J = 6.6 Hz, 2H), 3.08 (s, 1H), 1.20-1.80 (m, 11H), 1.38 (s, 3H), 1.33 (s, 3H), 0.82 (d, J = 
7.0 Hz, 3H);  
13
C NMR (CDCl3, 125 MHz) " ppm 159.1, 130.8, 129.2, 113.7, 100.5, 73.1, 72.5, 70.1, 68.3, 
66.6, 55.3, 40.6, 37.9, 35.8, 29.7, 26.2, 25.2, 24.6, 24.6, 12.7;  
HRMS calculated for C22H36NaO5 (M+Na)
+
 403.2460; found 403.2413 (ESI). 
172 
tert-butyl((R)-2-((4S,6R)-6-(5-(4-methoxybenzyloxy)pentyl)-2,2-dimethyl-1,3-dioxan-4-
yl)propoxy)dimethylsilane: S4 
PMBO
O O
Me
OH
MeMe
PMBO
O O
Me
OTBS
MeMe
TBSCl, Imidazole
DMAP, CH2Cl2
3.12 S4  
 Alcohol 3.12 (1.34 mg, 3.53 mmol) was taken up in CH2Cl2 (23 mL) at RT.  Imidazole 
(720 mg, 10.6 mmol), DMAP (10 mg, 0.08 mmol) and TBSCl (800 mg, 5.29 mmol) were added, 
respectively.  The reaction was quenched upon completion (~90 min) with sat. aq. NH4Cl and 
diluted with Et2O (50 mL).  The aqueous layer was extracted with Et2O (3 x 25 mL) and the 
organic layers were washed with brine (25 mL).  The combined organic layers were dried 
(Na2SO4) and concentrated under reduced pressure. Purification with flash chromatography 
(20:1, hexanes:EtOAc) produced S4 as a yellow oil in 97% yield (1.70 g).  
[!]D -16.6 (c = 0.35, CH2Cl2);  
FTIR neat 2933, 2856, 2881, 1247, 835 cm
 -1
;  
1
H NMR (CDCl3, 500 MHz) " ppm 7.26 (d, J = 8.4 Hz, 2H), 6.88 (d, J = 8.6 Hz, 2H), 4.24 (s, 
2H), 3.80 (s, 3H), 3.66-3.74 (m, 2H), 3.56 (d, J = 4.4 Hz, 2H), 3.44 (t, J = 6.6 Hz, 2H), 1.37-1.67 
(m, 11H), 1.31 (s, 6H), 0.89 (s, 9H), 0.85 (d, J = 6.8 Hz, 3H), 0.02 (s, 6H);  
13
C NMR (CDCl3, 125 MHz) " ppm 159.0, 130.7, 129.2, 113.7, 100.1, 72.5, 70.1, 67.0, 66.8, 
64.1, 55.2, 40.5, 36.6, 35.9, 29.7, 26.1, 25.9, 25.3, 24.6, 24.5, 18.2, 12.2, -5.5, -5.5;   
HRMS calculated for C28H50NaO5Si (M+Na)
+
 517.3325; found 517.3334 (ESI). 
173 
5-((4R,6S)-6-((R)-1-(tert-butyldimethylsilyloxy)propan-2-yl)-2,2-dimethyl-1,3-dioxan-4-
yl)pentan-1-ol: S5 
HO
O O
Me
OTBS
MeMe
PMBO
O O
Me
OTBS
MeMe
H2, Pd/C
NaHCO3
S4 S5  
 PMB ether S4 (1.65 g, 3.34 mmol) was taken up in EtOAc (16 mL) at RT.  A catalytic 
amount of 10% Pd/C (50 mg) and NaHCO3 (280 mg, 3.34 mmol) were added sequentially and 
the flask was pressurized with a H2 balloon.  After 10 hours the mixture was filtered through 
Celite® and rinsed thoroughly with EtOAc.  The filtrate was concentrated under reduced 
pressure and purified with flash chromatography (10:1, hexanes:EtOAc) to yield S5 as a clear oil 
(1.12 g, 90% yield). 
[!]D -0.11 (c = 0.40, CH2Cl2);  
FTIR (neat) 3357, 2933, 2858, 1379, 1251, 1224, 835, 775 cm
-1
;  
1
H NMR (CDCl3, 500 MHz)
10
 " ppm 3.72 (dd, J = 14.5 Hz, 2H) 3.60-3.67 (m, 2H), 3.55 (d, J = 
4.8 Hz, 2H), 1.38-1.70 (m, 10H), 1.33 (s, 6H), 1.22-1.28 (m, 1H), 0.89 (s, 9H), 0.84 (d, J = 6.9 
Hz, 3H), 0.04 (s, 6H);  
13
C NMR (CDCl3, 125 MHz) " ppm 100.2, 67.1, 66.8, 64.1, 63.0, 40.5, 36.6, 35.9, 32.7, 25.9 
(3), 25.7, 25.3, 24.6, 24.5, 18.2, 12.2, -5.5, -5.5;  
HRMS calculated for C20H42NaO4Si (M+Na)
+
 397.2750, found 397.2773 (ESI). 
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 Spectrum integrated to 41 total H, where the unassigned H was presumed to be an O-H peak 
undergoing H-D exchange. 
174 
 (R)-2-((4S,6R)-2,2-dimethyl-6-(pent-4-enyl)-1,3-dioxan-4-yl)propan-1-ol: 3.13 
HO
O O
Me
OTBS
MeMe
1. I2, PPh3
then tBuOK
2. TBAF
O O
Me
OH
MeMe
S5 3.13  
 Alcohol S5 (1.12 g, 2.99 mmol) was taken up in THF (30 mL) at RT.  
Triphenylphosphine (941 mg, 3.59 mmol) and imidazole (477 mg, 6.59 mmol) were added, 
respectively, and the solution was cooled to 0 ºC.  I2 (912 mg, 3.59 mmol) was added and the 
reaction was stirred for approximately 30 minutes (monitored by TLC).  The solution was diluted 
with hexane and filtered through a pad of silica, while washing with hexane, and concentrated 
under reduced pressure.  The crude product was taken onto the next step.  
The iodo compound was dissolved in THF (35 mL) at RT followed by stepwise addition 
of t-BuOK (1.0 g, 8.98 mmol).  The reaction was stirred for ~30 minutes and was quenched with 
H2O.  The aqueous layer was extracted with EtOAc (3 x 20 mL portions) and the organic layers 
were combined, washed with brine (20 mL), dried (Na2SO4) and concentrated under reduced 
pressure.  Purification with flash chromatography (20:1, hexanes:EtOAc) yielded the resultant 
terminal olefin (1.00 g) as a clear oil in 94% yield.  
The resultant silyl ether (1.00 g, 2.81 mmol) was dissolved in THF (10 mL) and cooled to 
0 ºC.  A solution of TBAF in THF (8.5 mL, 1.0 M in THF) was added dropwise.  The reaction 
was stirred at 0 ºC until completion (approximately 45 minutes).  The reaction was quenched 
with NH4Cl and the aqueous layer was extracted with Et2O (3x20 mL portions).  The organic 
layers were combined, washed with brine (20 mL), dried (Na2SO4) and concentrated under 
reduced pressure.  Purification using flash chromatography (10:1, hexanes:EtOAc) afforded 3.13 
as a clear oil (670 mg) in 98% yield.  
[!]D -78.6 (c = 0.50, CH2Cl2);  
175 
FTIR (neat) 3446, 2983, 2935, 2879, 1379, 1224, 908 cm
-1
;  
1
H NMR (CDCl3, 500 MHz) " ppm 5.75-5.86 (m, 1 H), 4.93-5.07 (m, 2 H), 3.76-3.82 (m, 1 H), 
3.69 (ddd, J = 9.2, 6.2 Hz, 1H), 3.55-3.61 (m, 2H), 3.08 (s, 1H), 2.06 (dd, J = 14.1, 7.1 Hz, 2H), 
1.40-1.80 (m, 7H), 1.38 (s, 3H), 1.33 (s, 3H), 0.81 (d, J = 7.0 Hz, 3H);  
13
C NMR (CDCl3, 125 MHz) " ppm 138.7, 114.7, 100.5, 73.0, 68.2, 66.6, 40.6, 37.8, 35.3, 33.6, 
24.7, 24.6, 24.6, 12.6;   
HRMS calculated for C14H27O3 (M+H)
+
 243.1960, found 243.2895 (ESI). 
 
176 
(2R,3R,7R,E)-2-((4S,6R)-2,2-dimethyl-6-(pent-4-enyl)-1,3-dioxan-4-yl)-5-methyl-7-
(triethylsilyloxy)dec-4-en-3-ol: 3.16 
O
Me
O O Me
nPr
OTES
Me Me
O
Me
O OH Me
nPr
OTES
Me Me
H
I
O
Me
O
Me Me
OH
Swern Ox.
tBuLi, Et2O,vinyl iodide, 
-78 ºC to 0 ºC 30 min;
then aldehyde, -78 ºC, 79 %
1) Dess-Martin
2) NaBH4, 0 ºC
3.13 3.14 3.15
3.16  
 A solution of oxalyl chloride (0.158 mL, 1.86 mmol) in CH2Cl2 (4.8 mL) was cooled to  
-78 ºC and DMSO (0.220 mL, 3.01 mmol) was added slowly by syringe (gas evolution).  After 
stirring for 10 minutes, a solution of alcohol 3.13 (300 mg, 1.24 mmol) in CH2Cl2 (3.0 mL) was 
added by cannula and rinsed with CH2Cl2 (2 x 0.5 mL).  The cloudy mixture was stirred at -78 ºC 
for 15 minutes at which time Et3N (0.700 mL, 4.96 mmol) was added dropwise.  The reaction 
mixture was stirred for 1 h at -78 ºC, quenched cold with sat. aq. NaHCO3 (5 mL) and allowed to 
warm to RT.  After diluting with CH2Cl2, the layers were separated and the aqueous layer was 
re-extracted with CH2Cl2 (3 x 12 mL).  The organic layer was dried (Na2SO4), filtered through a 
silica plug and rinsed (3 x 25 mL) with a 1:1 EtOAc:CH2Cl2.  The filtrate was concentrated 
under reduced pressure to give aldehyde 15 as a yellow oil.  The crude aldehyde 3.14 was taken 
immediately to the next reaction without further purification.   
To a solution of vinyl iodide 3.15 (1.01 mg, 2.75 mmol) in Et2O (10 mL) at  
–78 ºC was added t-BuLi (1.7 M in pentane, 3.40 mL, 5.75 mmol), and the reaction was 
immediately warmed to 0 ºC for 25 min.  The reaction was recooled to -78 ºC, and the aldehyde 
was slowly added via syringe in Et2O (2.5 mL, 0.60 mL rinse).  After 1 h, the reaction was 
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quenched at -78 ºC with NH4Cl (sat’d, aq), warmed to RT, and the layers were separated.  The 
aq. layer was extracted with Et2O (2x10 mL), and the combined organic layers washed with 
brine (15 mL), dried (Na2SO4) and concentrated under reduced pressure.  Flash chromatography 
(10:1, hexanes:EtOAc) afforded a 1:1 mixture of 1,3-syn and 1,3-anti 3.16 (ratio determined by 
1
H NMR analysis of crude reaction mixture, 464 mg, combined yield of diastereomers 77% over 
two steps). 
Oxidation/Reduction Sequence: 
 The 1,3-anti diastereomer (65 mg, 0.135 mmol) of 3.16 was dissolved in CH2Cl2 (2.6 
mL) at RT.  Dess-Martin periodinane (115 mg, 0.270 mmol) was added to the stirring solution, 
where upon completion (monitored by TLC), the reaction was diluted with Et2O (5 mL).  The 
organic layer was washed with sat. aq. NaHCO3 (2 x 5 mL) and dried (Na2SO4).  After filtration, 
the solvent was removed under reduced pressure and the residual oil was purified through a short 
plug of SiO2 (1:1, hexanes:EtOAc) providing a clear oil (40 mg, 85% yield). 
 The ketone (6 mg, 0.0125 mmol) was dissolved in MeOH and cooled to 0 ºC.  NaBH4 (11 
mg, 0.035 mmol) was added slowly and the mixture was stirred until the ketone was completely 
consumed (monitored by TLC).  The mixture was partitioned with H2O:Et2O (1:1 ratio, 10 mL) 
and the resultant aqueous layer was extracted with Et2O (3x5 mL).  The collected organic layers 
were washed with brine (5 mL) and dried (Na2SO4).  The epimeric ratio of the crude material 
was determined by 
1
H NMR analysis after filtration and removal of solvent under reduced 
pressure, (~2.7:1).  Flash chromatography (5:1 hexanes:EtOAc) provided a clear oil (4 mg, 89% 
yield). 
[!]D -8.1 (c = 1.3, CH2Cl2);  
FTIR (neat) 3456, 2954, 2935, 2875, 1458, 1379, 1224, 908 cm
-1
; 
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1
H NMR (CDCl3, 500 MHz) " ppm 5.82 (dddd, J = 16.9, 10.1, 6.7, 6.7 Hz, 1H), 5.16 (d, J = 9.1 
Hz, 1H), 5.01 (ddd, J = 17.1, 3.4, 1.5 Hz, 1H), 4.95 (d, J = 10.2 Hz, 1H), 4.27 (t, J = 8.7 Hz, 1H), 
3.99 (s, 1H), 3.74-3.84 (m, 3H), 2.27 (dd, J =14.1, 4.3, 1H), 2.16 (dd, J =8.7, 3.0, 1H), 2.06 (q, J 
= 7.0, 2H), 1.70 (s, 3H), 1.41 (s, 3H), 1.35 (s, 3H), 1.72-1.20 (m, 11H), 0.96 (t, J = 8.2 Hz, 9H), 
0.88 (t, J = 7.3 Hz, 3H), 0.71 (d, J = 6.9 Hz, 3H), 0.59 (q, J = 8.2 Hz, 6H);  
13
C NMR (CDCl3, 125 MHz) " ppm 138.6, 136.0, 128.8, 114.6, 100.6, 72.9, 72.4, 70.7, 66.6, 
48.5, 44.1, 38.7, 38.0, 35.2, 33.6, 24.7, 24.6, 24.5, 18.4, 17.3, 14.2, 11.6, 7.0, 5.0; 
HRMS Exact Mass calculated for C28H54NaO4Si (M+Na)
+
 505.3689; found 505.3674 (ESI). 
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(5S,7R,9S,12R,13S,14R)-15-(tert-butyldimethylsilyloxy)-13-(4-methoxybenzyloxy)-2,12,14-
trimethylpentadec-1-ene-5,7,9-triyl triacetate: 3.18 
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Me
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Me
Ac2O, Pyr.
CH2Cl, DMAP
3.17 3.18
 
 To a solution of triol 3.17 (132 mg, 0.232 mmol) in CH2Cl2 (3.3 mL) was added DMAP 
(3 mg, 0.023 mmol), pyridine (0.750 mL, 9.30 mmol), and acetic anhydride (0.450 mL, 4.65 
mmol).  The reaction was stirred until disappearance of starting material at RT (~2 h).  The 
reaction was diluted with EtOAc, quenched with NH4Cl (sat’d aq.), and the aqueous layer was 
re-extracted with EtOAc (3 x 10 mL).  The organic layer was washed with brine (10 mL), dried 
(Na2SO4), filtered and concentrated under reduced pressure.  Flash chromatography (5:1 
hexanes:EtOAc) provided 3.18 (151 mg) in 94% yield as a clear oil. 
[!]D +12.4 (c  =  0.50, CH2Cl2);  
FTIR (neat) 2956, 2929, 2883, 2856, 1739, 1514, 1461, 1247 cm
-1
;  
1
H NMR (400 MHz, CDCl3) ! ppm 7.26 (d, J = 8.7 Hz, 2H), 6.87 (d, J = 8.7 Hz, 2H), 4.97 
(dddd, J = 9.5, 6.2, 6.2, 3.1 Hz, 1H), 4.89 (m, 2H), 4.71 (s, 1H), 4.66 (s, 1H), 4.53 (d, J = 10.9 
Hz, 1H), 4.46 (d, J = 10.9 Hz, 1H), 3.80 (s, 3H), 3.71 (dd, J = 9.7, 5.3 Hz, 1H), 3.63 (dd, J = 9.7, 
3.3 Hz, 1 H), 3.25 (dd, J = 8.7, 2.4 Hz, 1 H), 1.99-2.07 (m, 2 H), 2.05 (s, 3H), 2.03 (s, 3H), 1.99 
(s, 3H), 1.92 (dddd, J = 18.7, 10.2, 4.4, 4.4 Hz, 1 H), 1.68-1.84 (m, 5H), 1.71 (s, 3H), 1.54-1.64 
(m, 4H), 1.38-1.46 (m, 1H), 1.22-1.34 (m, 1H), 0.92 (s, 9H), 0.90 (d, J = 2.3 Hz, 3H), 0.88 (d, J 
= 2.3 Hz, 3H), 0.06 (s, 6H); 
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13
C NMR (126 MHz, CDCl3) ! ppm 170.8, 170.7, 170.6, 159.1, 144.9, 131.7, 129.3, 113.9, 
110.5, 83.3, 74.6, 70.9, 70.3, 67.5, 65.1, 55.4, 39.2, 38.7, 38.6, 35.4, 33.5, 33.1, 32.3, 30.5, 26.1, 
22.6, 21.3, 21.3, 21.2, 18.5, 14.8, 13.6, -5.2, -5.2; 
HRMS Exact Mass calculated for C38H64NaO9Si (M+Na)
+
 715.4217; found 715.4213 (ESI). 
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(5S,7R,9S,12R,13S,14R)-15-hydroxy-13-(4-methoxybenzyloxy)-2,12,14-trimethylpentadec-
1-ene-5,7,9-triyl triacetate: 3.19 
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Me
THF, rt
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3.18 3.19
 
 To a solution of 3.18 (150 mg, 0.216 mmol) in THF (2.3 mL) was added TBAF (0.70 
mL, 1.0 M in THF).  The reaction was stirred until disappearance of starting material at RT (~3 
h).  The reaction was diluted with EtOAc (3 mL), quenched with NH4Cl (sat’d aq.), and the 
aqueous layer was re-extracted with EtOAc (2x5 mL).  The organic layer was dried (Na2SO4), 
filtered and concentrated under reduced pressure.  Flash chromatography (2:1, hexanes:EtOAc) 
provided 3.19 (118 mg) in 94% yield as a clear oil. 
[!]D +13.1 (c = 2.4, CH2Cl2);  
FTIR (neat) 3502, 3072, 2964, 2935, 2875, 1737, 1514, 1454, 1245 cm
-1
;  
1
H NMR (400 MHz, CDCl3) ! ppm 7.28 (d, J = 8.5 Hz, 2H), 6.88 (d, J = 8.6 Hz, 2H), 4.98 
(dddd, J = 9.6, 6.3, 6.3, 3.3 Hz, 1H), 4.85-4.99 (m, 2H), 4.73 (s, 1H), 4.67 (s, 1H), 4.58 (d, J = 
10.6 Hz, 1H), 4.51 (d, J = 10.6 Hz, 1H), 3.81 (s, 3H), 3.62-3.67 (m, 2H), 3.25 (dd, J = 7.6, 3.3 
Hz, 1H), 2.71 (s, 1H), 1.99-2.07 (m, 2H), 2.06 (s, 3H), 2.04 (s, 3H), 2.02 (s, 3H), 1.86-1.95 (m, 
2H) 1.68-1.84 (m, 6H), 1.72 (s, 3H), 1.56-1.64 (m, 2H), 1.44-1.54 (m, 1H), 1.22-1.34 (m, 1H), 
0.96 (d, J = 6.9 Hz, 3H), 0.94 (d, J = 7.1 Hz, 3H); 
13
C NMR (126 MHz, CDCl3) ! ppm 170.7, 170.6, 170.5, 159.3, 144.7, 130.4, 129.4 (2), 113.9 
(2), 110.4, 87.6, 74.8, 70.6, 70.0, 67.3, 66.5, 55.3, 39.0, 38.4, 37.7, 36.1, 33.3, 32.8, 32.2, 30.0, 
22.4, 21.2, 21.1, 21.1, 15.4, 14.3; 
HRMS Exact Mass calculated for C32H50NaO9 (M+Na)
+
 601.3353; found 601.3354 (ESI).
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(2S,3S,4R,7S,9R,11S)-7,9,11-triacetoxy-3-(4-methoxybenzyloxy)-2,4,14-trimethylpentadec-
14-enoic acid: 3.20 
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Me
2. NaH2PO4, NaHClO2
2-methyl-2-butene
1. Swern Ox.
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3.19 3.20
 
 A solution of oxalyl chloride (0.046 mL, 0.539 mmol) in CH2Cl2 (1.67 mL) was cooled to 
-78 ºC and DMSO (0.077 mL, 1.08 mmol) was added slowly by syringe (gas evolution).  After 
stirring for 10 minutes a solution of alcohol 3.19 (125 mg, 0.215 mmol) in CH2Cl2 (2.00 mL) was 
added by cannula and rinsed with CH2Cl2 (2 x 0.20 mL).  The cloudy mixture was stirred at -78 
ºC for 15 minutes at which time Et3N (0.180 mL, 1.29 mmol) was added dropwise.  The reaction 
mixture was stirred for 2 h at -78 ºC.  The reaction was quenched at -78 ºC with sat. aq. NaHCO3 
(3 mL) and allowed to warm to RT.  The reaction was diluted with CH2Cl2, and the layers were 
separated.  The aqueous layer was re-extracted with CH2Cl2 (3 x 5 mL).  The organic layer was 
dried (Na2SO4), filtered and concentrated under reduced pressure to give aldehyde S6 as a yellow 
oil.  The crude aldehyde was taken immediately to the next reaction with further purification.   
 To a solution of crude aldehyde S6 was added t-butanol (4.5 mL) and 2-methyl-2-butene 
(1.5 mL).  A solution of NaClO2 (390 mg, 4.30 mmol) and sodium dihydrogen phosphate (470 
mg, 3.01 mmol) in H2O (2.00 mL) was prepared and added to the reaction mixture by syringe.  
The yellow solution was stirred vigorously for 2 h at RT, diluted with Et2O (15 mL) and poured 
into H2O (9 mL).  The layers were separated and the aqueous phase was extracted with Et2O 
(3x10 mL).  The combine organic layers were dried (Na2SO4), filtered and concentrated under 
reduced pressure.  Flash chromatography (1:1 hexanes:EtOAc) provided 3.20 (104 mg)  in 81% 
yield (over two steps) as a clear oil. 
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[!]D +8.13 (c = 0.16, CH2Cl2);  
FTIR (neat) 3251, 3076, 2964, 2923, 2854, 1737, 1714, 1512, 1454, 1245 cm
-1
;  
1
H NMR (400 MHz, CDCl3) ! ppm 7.24 (d, J = 8.5 Hz, 2H), 6.85 (d, J = 8.6 Hz, 2H), 4.85-5.10 
(m, 3H), 4.73 (s, 1H), 4.67 (s, 1H), 4.56 (d, J = 10.7 Hz, 1H), 4.50 (d, J = 10.6 Hz, 1H), 3.79 (s, 
3H), 3.57 (dd, J = 7.2, 3.5 Hz, 1H), 2.78 (dddd, J = 14.33, 7.1, 7.1, 7.1 Hz, 1H), 1.99-2.07 (m, 
2H), 2.06 (s, 3H), 2.04 (s, 3H), 2.02 (s, 3H), 1.86-1.95 (m, 2H) 1.64-1.84 (m, 5H), 1.72 (s, 3H), 
1.40-1.64 (m, 3H), 1.20-1.39 (m, 2H), 1.17 (d, J = 7.1 Hz, 3H), 0.93 (d, J = 6.7 Hz, 3H); 
13
C NMR (126 MHz, CDCl3) ! ppm 177.3, 170.8, 170.7, 170.5, 159.4, 144.7, 130.0, 129.5 (2), 
113.9 (2), 110.3, 84.2, 74.4, 70.8, 69.9, 67.3, 55.3, 42.3, 39.0, 38.1, 35.6, 33.3, 32.5, 32.3, 28.9, 
22.4, 21.2, 21.1, 21.1, 14.7, 14.4; 
HRMS Exact Mass calculated for C32H48NaO10 (M+Na)
+
 615.3145; found 615.3131 (ESI). 
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(5S,7R,9S,12R,13S,14S)-15-((2S,3R,7R,E)-2-((4S,6R)-2,2-dimethyl-6-(pent-4-enyl)-1,3-
dioxan-4-yl)-5-methyl-7-(triethylsilyloxy)dec-4-en-3-yloxy)-13-(4-methoxybenzyloxy)-
2,12,14-trimethyl-15-oxopentadec-1-ene-5,7,9-triyl triacetate: 3.21 
O
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3.16 3.21  
 To a solution of alcohol 3.16 (77 mg, 0.159 mmol), carboxylic acid 3.20 (106 mg, 0.175 
mmol), and DMAP (975 mg, 7.98 mmol) in toluene (32 mL) at -78 ºC was added Et3N (0.503 
mL, 3.61 mmol) dropwise followed by the slow addition of 2,4,6-trichlorobenzoyl chloride 
(0.560 mL, 3.58 mmol), which caused the white solution to thicken.  The mixture was stirred for 
21 h at -78 ºC ensuring that the bath temperature did not rise above -65 ºC.  The reaction flask 
was then moved to a dry ice/CH3CN bath and stirred for 2.5 h maintaining the temperature 
between -30 ºC to -42 ºC.  At the end of the 2.5 h the solution was slowly allowed to warm to RT 
in the bath over 1 h.  The flask was placed in an ice bath for 2 h while being stirred.  The reaction 
was quenched by the addition of sat. aq. NaHCO3 (15 mL).  The layers were separated and the 
aqueous layer was back extracted with Et2O (25 mL).  The combined organic layers were dried 
(Na2SO4), filtered, and concentrated under reduce pressure.  Purification by flash 
chromatography (5:1, hexanes:EtOAc) provided ester 3.21 (130 mg) in 77% yield as a colorless 
oil.    
[!]D +3.63 (c  =  0.28, CH2Cl2);  
FTIR (neat) 3076, 2954, 2935, 2875, 1739, 1515, 1442, 1244 cm
-1
;  
185 
1
H NMR (400 MHz, CDCl3) ! ppm 7.19 (d, J = 8.7 Hz, 2H), 6.83 (d, J = 8.7 Hz, 2H), 5.82 
(dddd, J = 17.0, 10.2, 6.8, 6.8 Hz, 1H), 5.68 (dd, J = 9.9, 5.7 Hz, 1H), 5.17 (d, J = 9.8 Hz, 1H), 
5.02 (ddd, J = 17.1, 3.2, 1.6 Hz, 1H), 4.93-5.00 (m, 3H), 4.85-4.94 (m, 2H), 4.74 (s, 1H), 4.67 (s, 
1H), 4.51 (d, J = 10.8 Hz, 1H), 4.34 (d, J = 10.8 Hz, 1H), 3.79 (s, 3H), 3.70-3.80 (m, 2H), 3.60-
3.69 (m, 3H), 2.69 (dt, J = 14.2, 7.1 Hz, 1H), 1.89-2.20 (m, 8H), 2.06 (s, 3H), 2.04 (s, 3H), 2.00 
(s, 3H), 1.76 (s, 3H), 1.73 (s, 3H), 1.34 (s, 3H), 1.29 (s, 3H), 1.20-1.80 (m, 18H), 1.08 (d, J = 7.1 
Hz, 3H), 0.96 (t, J = 7.9 Hz, 9H), 0.84-0.93 (m, 9H) 0.58 (q, J = 7.9 Hz, 6H); 
13
C NMR (126 MHz, CDCl3) ! ppm 175.3, 170.6, 170.6, 170.5, 158.9, 144.7, 139.6, 138.8, 
131.2, 129.0, 122.7, 114.6, 113.6, 110.3, 100.1, 83.1, 73.9, 71.4, 70.7, 70.2, 70.0, 67.3, 67.1, 
66.5, 55.2, 53.5, 48.8, 43.5, 42.1, 39.1, 38.5, 38.5, 35.4, 34.7, 33.7, 33.3, 32.1, 30.3, 29.9, 29.7, 
24.9, 24.9, 24.8, 22.4, 21.2, 21.1, 21.1, 18.3, 17.6, 15.3, 14.8, 14.2, 13.2, 9.8, 7.0 (3), 5.0 (3); 
HRMS Exact Mass calculated for C60H100NaO13Si (M+Na)
+
 1079.6831; found 1079.7115 (ESI). 
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(5S,7R,9S,12R,13S,14S)-15-((2S,3R,7R,E)-2-((4S,6R)-2,2-dimethyl-6-(pent-4-enyl)-1,3-
dioxan-4-yl)-7-hydroxy-5-methyldec-4-en-3-yloxy)-13-(4-methoxybenzyloxy)-2,12,14-
trimethyl-15-oxopentadec-1-ene-5,7,9-triyl triacetate: S7 
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3.21 S7  
Ester 3.21 (75 mg, 0.071 mmol) was dissolved in THF (1 mL) and cooled to 0 ºC.  A 
solution of TBAF in THF (0.214 mL, 1.0 M in THF) was added dropwise.  The reaction stirred 
at 0 ºC until completion (approximately 45 minutes).  The reaction was quenched with sat. aq. 
NH4Cl and the aqueous layer was extracted with EtOAc (3 x 10 mL portions).  The organic 
layers were combined, washed with brine (5 mL), dried (Na2SO4), filtered and concentrated 
under reduced pressure.  Purification by flash chromatography (2:1, hexanes:EtOAc) afforded S7 
(63 mg) as a clear oil in 94% yield.  
[!]D -11.4 (c  =  1.0, CHCl3);  
1
H NMR (400 MHz, CDCl3) ! ppm 7.22 (d, J = 8.7 Hz, 2H), 6.84 (d, J = 8.7 Hz, 2H), 5.81 
(dddd, J = 17.0, 10.2, 6.7, 6.7 Hz, 1H), 5.64 (dd, J = 9.9, 5.2 Hz, 1H), 5.20 (d, J = 9.6 Hz, 1H), 
5.01 (ddd, J = 17.1, 3.4, 1.6 Hz, 1H), 4.93-5.00 (m, 2H), 4.85-4.93 (m, 2H), 4.72 (s, 1H), 4.67 (s, 
1H), 4.53 (d, J = 10.7 Hz, 1H), 4.38 (d, J = 10.7 Hz, 1H), 3.79 (s, 3H), 3.69-3.76 (m, 1H), 3.59-
3.66 (m, 1H), 3.60-3.54 (m, 1H), 3.53 (dd, J = 8.4, 3.0 Hz, 1H), 2.70 (dt, J = 15.2, 7.2 Hz, 1H), 
1.87-2.15 (m, 8H), 2.06 (s, 3H), 2.04 (s, 3H), 2.00 (s, 3H), 1.20-1.80 (m, 21H), 1.76 (s, 3H), 1.73 
(s, 3H), 1.33 (s, 3H), 1.28 (s, 3H), 1.10 (d, J = 7.1 Hz, 3H), 0.84-0.93 (m, 9H); 
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13
C NMR (126 MHz, CDCl3) ! ppm 175.3, 170.7, 170.6, 170.5, 158.9, 144.7, 139.6, 138.7, 
131.2, 128.8, 123.1, 114.6, 113.5, 110.3, 100.2, 83.7, 73.8, 71.8, 70.7, 70.0, 68.4, 67.3, 66.4, 
55.2, 53.5, 48.1, 43.4, 42.1, 39.2, 39.1, 38.5, 36.3, 35.4, 35.1, 33.7, 33.3, 32.8, 32.2, 29.8, 29.7, 
24.8, 24.6, 22.4, 21.2, 21.1, 21.0, 18.9, 17.5, 14.8, 14.2, 13.6, 9.9; 
HRMS Exact Mass calculated for C54H86NaO13 (M+Na)
+
 965.5966; found 965.5897 (ESI). 
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(5S,7R,9S,12R,13S,14S)-15-((2S,3R,7R,E)-7-acetoxy-2-((4S,6R)-2,2-dimethyl-6-(pent-4-
enyl)-1,3-dioxan-4-yl)-5-methyldec-4-en-3-yloxy)-13-(4-methoxybenzyloxy)-2,12,14-
trimethyl-15-oxopentadec-1-ene-5,7,9-triyl triacetate: 3.22 
 
O
Me
O Me
nPr
OH
OAcOAc
Me
PMBO
Me
O
OAc
Me
O
Ac2O, pyr.
Me Me DMAP, CH2Cl2
O
Me
O Me
nPr
OAc
OAcOAc
Me
PMBO
Me
O
OAc
Me
O
Me Me
S7 3.22  
 To a solution of S7 (58 mg, 0.0616 mmol) in CH2Cl2 (3.0 mL) was added DMAP (1 
crystal), pyridine (0.200 mL, 2.46 mmol) and acetic anhydride (0.117 mL, 1.23 mmol).  The 
reaction was stirred at RT until disappearance of starting material (~2 h).  The reaction was 
diluted with EtOAc, quenched with NH4Cl (sat’d aq.) and the aqueous layer was re-extracted 
with EtOAc (3 x 5 mL).  The organic layer was washed with brine (5 mL), dried (Na2SO4), 
filtered and concentrated under reduced pressure.  Flash chromatography (1.5:1, hexanes:EtOAc) 
provided 3.22 (60 mg) in 98% yield as a clear oil. 
[!]D +2.2 (c  =  1.0, CHCl3);  
1
H NMR (400 MHz, CDCl3) ! ppm 7.18 (d, J = 8.6 Hz, 2H), 6.83 (d, J = 8.6 Hz, 2H), 5.80 
(dddd, J = 16.9, 10.2, 6.7, 6.7 Hz, 1H), 5.67 (dd, J = 9.9, 5.6 Hz, 1H), 5.16 (d, J = 9.7 Hz, 1H), 
5.00 (ddd, J = 17.1, 3.4, 1.6 Hz, 1H), 4.92-5.00 (m, 3H), 4.84-4.92 (m, 2H), 4.73 (s, 1H), 4.66 (s, 
1H), 4.50 (d, J = 10.9 Hz, 1H), 4.35 (d, J = 10.9 Hz, 1H), 3.79 (s, 3H), 3.68-3.75 (m, 1H), 3.55-
3.62 (m, 2H), 2.68 (dt, J = 16.0, 6.9, 1H), 1.87-2.15 (m, 8H), 2.06 (s, 3H), 2.04 (s, 3H), 2.02 (s, 
3H), 2.00 (s, 3H), 1.20-1.80 (m, 20H), 1.77 (s, 3H), 1.73 (s, 3H), 1.33 (s, 3H), 1.27 (s, 3H), 1.06 
(d, J = 7.1 Hz, 3H), 0.84-0.93 (m, 9H); 
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13
C NMR (126 MHz, CDCl3) ! ppm 175.1, 170.6, 170.6, 170.6, 170.5, 158.9, 144.7, 138.7, 
138.6, 131.3, 128.8, 122.5, 114.6, 113.5, 110.3, 100.2, 83.2, 73.8, 72.1, 71.2, 70.7, 70.0, 67.3, 
66.4, 55.2, 53.5, 44.2, 42.1, 39.2, 39.1, 35.9, 35.4, 33.7, 33.3, 32.2, 31.9, 31.6, 29.9, 24.8, 24.8, 
22.7, 21.3, 21.2, 21.1, 21.0, 18.4, 17.8, 14.7, 14.2, 14.2, 14.0, 13.2, 9.7; 
HRMS Exact Mass calculated for C56H88NaO14 (M+Na)
+
 1007.6072; found 1007.6210 (ESI). 
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(5S,7R,9S,12R,13S,14S)-15-((4R,8R,9S,10S,12R,E)-4-acetoxy-10,12-dihydroxy-6,9-
dimethylheptadeca-6,16-dien-8-yloxy)-13-(4-methoxybenzyloxy)-2,12,14-trimethyl-15-
oxopentadec-1-ene-5,7,9-triyl triacetate: S8 
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3.22 S8  
 To a solution of tetraacetate 3.22 (60 mg, 0.0609 mmol) in MeOH (6 mL) was added 
PPTS (2.5 mg, 0.0305 mmol). The reaction was stirred until disappearance of starting material at 
RT (~ 4 h).  The reaction was diluted with EtOAc, quenched with NaHCO3 (sat’d aq.) and the 
aqueous layer was re-extracted with EtOAc (3 x 10 mL).  The organic layer was washed with 
brine (10 mL), dried (Na2SO4), filtered and concentrated under reduced pressure.  Flash 
chromatography (1.5:1, hexanes:EtOAc) provided S8 (47 mg) in 82% yield as a clear oil. 
[!]D +8.97 (c  = 1.7, CHCl3);  
1
H NMR (400 MHz, CDCl3) ! ppm 7.21 (d, J = 8.3 Hz, 2H), 6.85 (d, J = 8.4 Hz, 2H), 5.82 
(dddd, J = 15.8, 12.1, 5.4, 5.4 Hz, 1H), 5.69 (dd, J = 9.7, 6.0 Hz, 1H), 5.18 (d, J = 9.8 Hz, 1H), 
4.85-5.05 (m, 6H), 4.73 (s, 1H), 4.67 (s, 1H), 4.51 (d, J = 10.9 Hz, 1H), 4.34 (d, J = 11.0 Hz, 
1H), 3.86-3.92 (m, 1H), 3.80 (s, 3H), 3.71 (m, 1H), 3.58 (dd, J = 8.4, 2.0 Hz, 1H), 2.73 (dddd, J 
= 14.2, 6.8, 6.8, 6.8 Hz, 1H), 1.19-2.50 (m, 28H), 2.07 (s, 3H), 2.03 (s, 3H), 2.02 (s, 3H), 1.82 (s, 
3H), 1.72 (s, 3H), 1.09 (d, J = 7.0 Hz, 3H), 0.89 (t, J = 7.3 Hz, 3H), 0.81-0.86 (m, 9H); 
13
C NMR (126 MHz, CDCl3) ! ppm 175.1, 170.7, 170.6, 170.6, 170.5, 158.9, 144.7, 138.7, 
138.6, 131.1, 128.4, 123.4, 114.7, 113.7, 110.3, 83.5, 73.8, 73.5, 72.5, 70.7, 70.1, 68.8, 67.3, 
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60.4, 55.2, 44.3, 43.4, 43.0, 39.5, 39.1, 38.5, 37.1, 36.3, 34.9, 33.7, 33.3, 32.2, 31.6, 29.8, 25.1, 
22.7, 21.3, 21.2, 21.1, 21.1, 18.4, 17.8, 14.2, 14.0, 13.6, 10.8;  
HRMS Exact Mass calculated for C53H84NaO14 (M+Na)
+
 967.5759; found 967.5789 (ESI).
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(5S,7R,9S,12R,13S,14S)-15-((4R,8R,9S,10S,12R,E)-4-acetoxy-10,12-dihydroxy-6,9-
dimethylheptadeca-6,16-dien-8-yloxy)-13-hydroxy-2,12,14-trimethyl-15-oxopentadec-1-ene-
5,7,9-triyl triacetate: 3.23 
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S8 3.23  
 Ester S8 (105 mg, 0.112 mmol) was taken up in CH2Cl2 (5.0 mL) followed by the 
addition of pH = 7 buffer solution (5.0 mL) and DDQ (51 mg, 0.224 mmol) at RT.  Upon 
completion (~0.5 h, monitored by TLC), CH2Cl2 (13 mL) was added followed by NaHCO3 (sat’d 
aq, 1 mL).  The layers were separated, and the aq. layer extracted with CH2Cl2 (3 x 10 mL).   The 
combined organic layers were washed with brine (10 mL), dried (anhydrous Na2SO4), filtered, 
and concentrated under reduced pressure.  Flash chromatography (2:1, hexanes:EtOAc) afforded 
3.23 (89 mg) in 97% yield as a clear oil.  
[!]D +4.4 (c  = 0.50, CHCl3);  
1
H NMR (400 MHz, CDCl3) ! ppm 5.79 (dddd, J = 17.0, 10.2, 6.7, 6.7 Hz, 1H), 5.19 (dd, J = 
9.7, 9.5 Hz, 1H), 4.87-5.07 (m, 6H), 4.73 (s, 1H), 4.66 (s, 1H), 4.09-4.15 (m, 2H), 3.89-3.96 (m, 
1H), 3.71 (dd, J = 9.9, 1.2 Hz, 1H), 2.54 (dddd, J = 14.1, 7.0, 7.0, 7.0 Hz, 1H), 1.19-2.17 (m, 
28H), 2.07 (s, 3H), 2.03 (s, 3H), 2.02 (s, 3H), 1.82 (s, 3H), 1.72 (s, 3H), 1.08 (d, J = 7.0 Hz, 3H), 
0.89 (t, J = 7.3 Hz, 3H), 0.81-0.86 (m, 9H); 
13
C NMR (126 MHz, CDCl3) " ppm 174.0, 172.4, 170.8, 170.8, 170.6, 144.6, 138.7, 138.0, 
125.3, 114.6, 110.4, 72.6, 72.6, 72.4, 71.9, 70.7, 68.1, 67.1, 66.9, 45.3, 44.2, 42.7, 39.0, 37.6, 
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37.3, 36.9, 36.0, 33.7, 33.6, 33.3, 32.3, 31.5, 29.0, 25.3, 22.4, 21.4, 21.3, 21.2, 21.1, 18.5, 17.8, 
13.9, 13.6, 12.5, 9.5; 
HRMS Exact Mass calculated for C45H76NaO13 (M+Na)
+
 847.5184; found 847.5183 (ESI). 
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(3S,4S,5R,8S,10R,12S,20R,22S,23S,24R,E)-24-((R,E)-4-acetoxy-2-methylhept-1-enyl)-
4,20,22-trihydroxy-3,5,15,23-tetramethyl-2-oxooxacyclotetracos-15-ene-8,10,12-triyl 
triacetate, Dolabelide C: 3.1 
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3.23  
 To a refluxing solution of ester 3.23 (70 mg, 0.0849 mmol) in degassed CH2Cl2 (175 mL) 
was added Grubbs II catalyst (8.0 mg, 0.00849 mmol). The reaction was refluxed 2 h with the 
addition of more catalyst (4.0 mg, 0.00425 µmol) after 2 h.  A third portion of catalyst (4.0 mg, 
0.00425) was had after 2 more hours, the reaction was refluxed for 6 hours (monitored by TLC 
and LC-MS).  The solution was cooled to RT and concentrated under reduced pressure. The 
resultant residue was purified via flash chromatography through two sequential columns (8:1 
CH2Cl2/acetone) and (5:1, pentane/EtOAc) delivered 3.1, (14.0 mg, 21% yield) as an analytically 
pure sample and its C14-C15 Z-configured diastereomer (10 mg, 15% yield) (vide infra).  
[!]D +2.9 (c = 0.63, CHCl3);  
1
H NMR (500 MHz, pyridine-d5)11 ! ppm 5.90-6.10 (br m, 1H), 5.70 (t, J = 9.3 Hz, 1H), 5.67 (s, 
1H), 5.40 (d, J = 9.5 Hz, 1H), 5.31-5.38 (m, 2H), 5.23-5.30 (m, 2H), 5.10-5.16 (m, 1H), 4.82-4.88 
(m, 1H), 4.32-4.37 (m, 1H), 4.03 (br d, J =9.1 Hz, 1H), 2.85-2.93 (m, 1H), 2.48-2.52 (m, 1H), 2.32 
(dd, J = 14.0, 7.9 Hz, 1H), 2.28 (dd, J = 13.9, 5.4 Hz, 1H), 2.15-2.21 (m, 1H), 2.00-2.11 (m, 6H), 
2.08 (s, 3H), 2.06 (s, 3H), 2.05 (s, 3H), 2.05 (s, 3H), 1.98 (s, 3H), 1.92-1.96 (m, 2H), 1.80-1.90 (m, 
4H), 1.58-1.79 (m, 7H), 1.59 (s, 3H), 1.49-1.53 (m, 3H), 1.28-1.32 (m, 2H), 1.19 (d, J = 7.3 Hz, 
                                                
11
 Spectrum integrated to 71 total H, where the unassigned H was presumed to be an O-H peak 
undergoing H-D exchange.  Only the O-H peaks did not match exactly to the reported data. 
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3H), 1.16 (d, J = 7.0 Hz, 3H), 0.90 (d, J = 6.6 Hz, 3H), 0.84 (t, J = 7.3 Hz, 3H); 
13
C NMR (126 MHz, pyridine-d5) ! ppm 173.9, 170.6, 170.5, 170.4, 170.3, 136.7, 132.6, 127.3, 
127.2, 74.3, 73.5, 71.8, 69.9, 69.9, 68.0, 67.9, 67.3, 46.4, 44.5, 43.7, 38.8, 38.5, 38.0, 37.2, 36.3, 
35.2, 34.1, 31.8, 31.6, 29.3, 28.0, 27.0, 21.1, 21.0, 20.9, 20.9, 18.8, 17.6, 15.2, 14.0, 13.8, 12.6, 
11.0; 
1
H NMR (500 MHz, CDCl3) ! ppm 5.35 (t, J = 9.1 Hz, 1H), 5.05-5.10 (m, 2H), 5.00-5.04 (m, 
1H), 4.92-4.98 (m, 1H), 4.82-4.88 (m, 2H), 4.08 (s, 1H), 3.93 (s, 1H), 3.57 (s, 1H), 3.24 (s, 1H), 
2.54-2.60 (m, 1H), 2.47-2.54 (m, 1H), 2.25 (dd, J = 7.1, 13.8 Hz, 1H), 2.21 (dd, J = 5.7, 14.1 Hz, 
1H), 2.07 (s, 3H), 2.03 (s, 3H), 2.02 (s, 3H), 2.01 (s, 3H), 1.83-1.90 (m, 2H), 1.81 (s, 3H), 1.64-
1.78 (m, 3H), 1.62-1.64 (m, 4H), 1.58 (s, 3H), 1.44-1.56 (m, 9H), 1.20-1.43 (m, 9H), 1.07 (d,  J = 
7.1 Hz, 3H), 0.89 (t,  J = 7.3 Hz, 3H), 0.84 (m, 6H); 
13
C NMR (126 MHz, CDCl3) ! 173.8, 171.2, 171.0, 170.7, 170.4, 137.9, 133.1, 126.1, 125.0, 74.6, 
73.1, 72.2, 69.8, 69.2, 68.7, 68.1, 67.7, 45.1, 44.3, 42.7, 39.1, 36.8, 36.1, 35.1, 34.6, 31.9, 31.7, 29.7, 
28.3, 26.7, 25.0, 21.2, 21.2, 21.2, 21.1, 18.5, 17.7, 15.2, 13.9, 13.6, 12.6, 10.6; 
HRMS Exact Mass calculated for C43H72NaO13 (M+Na)
+
 819.4871; found 819.4858 (ESI). 
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Spectral Data for C14-C15 Z-Diastereomer 4.1 
1
H NMR (500 MHz, pyridine-d5)12 ! 6.28 (br s , 1 H), 6.05-6.20 (br m, 1 H), 5.85 (t, J = 9.4 Hz, 1 
H), 5.51 (d, J = 8.8 Hz, 1 H), 5.40-5.48 (m, 2 H), 5.40-5.48 (m, 2 H), 5.29-5.38 (m, 2 H), 5.18-5.27 
(m, 1 H), 4.84-4.88 (m, 1 H), 4.46-4.53 (m, 1 H), 4.14 (br d, J = 7.4 Hz, 1 H), 2.97-3.03 (m, 1 H), 
2.56-2.64 (m, 1 H), 2.43 (dd, J = 7.5, 13.8 Hz, 1 H), 2.37 (dd, J = 5.3, 13.1 Hz, 1 H), 2.23-2.34 (m, 
3 H), 2.19-2.22 (m, 1 H), 2.14-2.18 (m, 12 H),13 2.12-2.13 (m, 1 H), 2.08 (s, 3 H), 2.02-2.06 (m, 1 
H), 2.00-2.02 (m, 1 H), 1.95-1.99 (m, 2 H), 1.91-1.95 (m, 1 H), 1.86-1.91 (m, 2 H), 1.79-1.81 (m, 1 
H), 1.77 (s, 3 H), 1.66-1.75 (m, 3 H), 1.58-1.64 (m, 2 H); 1.31-1.49 (m, 4 H), 1.21-1.31 (m, 6 H), 
1.04 (d,  J = 6.6 Hz, 2 H), 0.94 (t,  J = 7.3 Hz, 3 H); 
13
C NMR (126 MHz, pyridine-d5) ! ppm 174.2, 170.9, 170.9, 170.7, 170.6, 137.2, 134.3, 127.3, 
126.9, 75.2, 73.6, 72.2, 71.8, 70.1, 68.3, 68.2, 68.1, 46.6, 44.8, 44.3, 39.9, 39.2, 39.0, 37.6, 36.7, 
34.4, 32.8, 32.0, 29.3, 28.4, 27.9, 27.5, 23.3, 21.4, 21.4, 21.3, 21.3, 19.1, 17.9, 14.3, 14.3, 13.0, 
11.4; 
1
H NMR (500 MHz, CDCl3)
14 ! ppm 5.07-5.13 (m, 2H), 4.97-5.03 (m, 3H), 4.91-4.96 (m, 1H), 
4.85-4.90 (m, 1H), 4.27 (s, 1H), 4.01-4.05 (m, 1H), 3.68 (d, J = 9.7 Hz, 1H), 2.54 (tt, J = 7.0 Hz, 
1H), 2.20-2.31 (m, 4H), 2.13-2.11 (m, 1H), 2.08-2.11 (m, 1H), 2.04-2.06 (m, 2H), 2.03-2.04 (m, 
6H), 2.02 (s, 3H), 2.01 (s, 3H), 1.97-2.00 (m, 1H), 1.95-1.97 (m, 1H), 1.82 (s, 3H), 1.76-1.81 (m, 
2H), 1.74-1.76 (m, 1H), 1.74-1.71 (m, 1H), 1.66 (s, 3H), 1.61 (s, 1H), 1.58-1.56 (m, 1H), 1.46-1.48 
(m, 2H), 1.43-1.45 (m, 2H), 1.39-1.42 (m, 2H), 1.25-1.38 (m, 6H), 1.01 (d, J = 7.0 Hz, 3H), 0.89 (t, 
J = 7.3 Hz, 3H), 0.82 (d, J = 7.0 Hz, 3H), 0.79 (d, J = 6.7 Hz, 3H);  
13
C NMR (126 MHz, CDCl3) ! ppm 173.6, 171.6, 171.3, 170.7, 170.4, 137.6, 133.9, 125.9, 125.8, 
74.0, 72.8, 72.3, 71.3, 70.8, 68.0, 67.0, 66.6, 45.7, 44.1, 42.9, 38.0, 37.4, 37.0, 35.9, 34.9, 33.6, 32.2, 
                                                
12
 Spectrum integrated to 69 total H, where the unassigned H resonances were presumed to be an 
O-H peaks undergoing H-D exchange. 
13 
Spectrum shown integrates to 11H.  An integration from " 2.23-2.07 resulted in a 19H 
multiplet, where the known signals were subtracted around " 2.22#2.19 resulting in a 12H signal. 
14
 Spectrum integrated to 69 total H, where the unassigned H's were presumed to be O-H peaks 
undergoing H-D exchange. 
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31.1, 28.2, 26.7, 25.9, 22.8, 21.4, 21.2, 21.2, 21.2, 21.2, 18.5, 17.8, 13.9, 13.4, 11.5, 9.36; 
[!]D +10.0 (c  = 0.30, CHCl3);  
HRMS Exact Mass calculated for C43H72NaO13 (M+Na)
+
 819.4871; found 819.4877 (ESI). 
HPLC-MS Analysis of 3.1 
HPLC data was collected using the following gradient over 35 minutes: 
Time (min) A% (99:1 H2O:MeCN) B% (99:1 MeCN: H2O) Flow Rate (mL/min) 
0.00 95.0 5.0 1.000 
1.00 40.0 60.0 1.000 
31.00 30.0 70.0 1.000 
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Dolabelide C (3.1), E-Isomer in pyridine-D5 
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Dolabelide C (3.1), E-Isomer in CDCl3 
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Dolabelide C, Z-Isomer (4.1) in pyridine-D5 
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Dolabelide C, Z-Isomer (4.1) in CDCl3 
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